<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head><title>
	Synthesis of Fluorinated Heterobicyclic Nitrogen Systems Containing 1,2,4-Triazine Moiety as CDK2 Inhibition Agents
</title><meta charset="utf-8" /><meta http-equiv="X-UA-Compatible" content="IE=edge" /><meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no" /><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="format-detection" content="telephone=no" /><meta name="robots" content="all" /><link href="//www.scirp.org/favicon.ico" rel="shortcut icon" /><meta name="MSSmartTagsPreventParsing" content="True" /><meta http-equiv="MSThemeCompatible" content="Yes" />
    <script type="text/javascript" src="//www.scirp.org/js/jquery.js"></script>
    <link href="//www.scirp.org/css/bootstrap.min.css" rel="stylesheet" /><link href="//www.scirp.org/css/font-awesome.min.css" rel="stylesheet" /><link href="//www.scirp.org/css/styletwo.css" rel="stylesheet" /><link href="https://fonts.googleapis.com/css?family=Open+Sans" rel="stylesheet" /><link href="https://fonts.googleapis.com/css?family=Poppins:300,500,600,700,800" rel="stylesheet" />
    <script src="//www.scirp.org/js/modernizr.js" type="text/javascript"></script>   

    
    <link rel="alternate" type="application/pdf" title="PDF Full-Text" href="//www.scirp.org/pdf/IJOC_2015092816192965.pdf" />

    
    <link rel="alternate" type="text/html" title="HTML Full-Text" href="//www.scirp.org/journal/paperinformation?paperid=60000" />
    
    <link rel="alternate" type="text/xml" title="XML Full-Text" href="//www.scirp.org/xml/60000.xml" />
    
    <link rel="canonical" href="https://www.scirp.org/journal/paperinformation?paperid=60000" />


<meta property="og:site_name" content="SCIRP" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://www.scirp.org/journal/paperinformation?paperid=60000" />
<meta property="og:title" content="Synthesis of Fluorinated Heterobicyclic Nitrogen Systems Containing 1,2,4-Triazine Moiety as CDK2 Inhibition Agents" />


<meta property="og:image" content="https://file.scirp.org/image/IJOC2016063009574360.jpg" />
<meta property="og:image:secure_url" content="https://file.scirp.org/image/IJOC2016063009574360.jpg" />





 <script type="text/javascript">

     var ajaxj = {
         tryList: function () {
             var xhrj = null;
             for (var i = 0; i < arguments.length; i++) {
                 var lambda = arguments[i];
                 try { xhrj = lambda(); break; } catch (e) { }
             }
             return xhrj;
         },
         init: function () {
             return this.tryList(
         function () { return new ActiveXObject('MSXML2.XMLHttp.6.0'); },
         function () { return new ActiveXObject('MSXML2.XMLHttp.3.0'); },
         function () { return new XMLHttpRequest(); },
         function () { return new ActiveXObject('MSXML2.XMLHttp.5.0'); },
         function () { return new ActiveXObject('MSXML2.XMLHttp.4.0'); },
         function () { return new ActiveXObject('Msxml2.XMLHTTP'); },
         function () { return new ActiveXObject('MSXML.XMLHttp'); },
         function () { return new ActiveXObject('Microsoft.XMLHTTP'); }
         ) || null;
         },
         post: function (sUrl, sArgs, bAsync, fCallBack, errmsg) {
             var xhrj = this.init();
             xhrj.onreadystatechange = function () {
                 if (xhrj.readyState == 4) {

                     if (xhrj.responseText) {
                         if (fCallBack.constructor == Function) { fCallBack(xhrj); }
                     } else {

                     }
                 }
             };
             xhrj.open('POST', encodeURI(sUrl), bAsync);

             xhrj.setRequestHeader('Content-Type', 'application/x-www-form-urlencoded');
             xhrj.send(sArgs);
         },
         get: function (sUrl, bAsync, fCallBack, errmsg) {
             var xhrj = this.init();
             xhrj.onreadystatechange = function () {
                 if (xhrj.readyState == 4) {
                     if (xhrj.responseText) {
                         if (fCallBack.constructor == Function) { fCallBack(xhrj); }
                     } else {

                     }
                 }
             };
             xhrj.open('GET', encodeURI(sUrl), bAsync);
             xhrj.send('Null');
         }
     }

     function RndNum(n) {
         var rnd = "";
         for (var i = 0; i < n; i++)
             rnd += Math.floor(Math.random() * 10);
         return rnd;
     }

     function SetNum(item) {
         var url = "//www.scirp.org/journal/senddownloadnum";
         var args = "paperid=" + item;
         url = url + "?" + args + "&rand=" + RndNum(4);
         window.setTimeout("show('" + url + "')", 3000);
     }


     function show(url) {
         var callback = function (xhrj) { }
         ajaxj.get(url, true, callback, "try");
     }


        </script>

        <script type="text/javascript">
            var ajax2 = {//xmlhttp request
                tryList: function () {
                    var xhr2 = null;
                    for (var i = 0; i < arguments.length; i++) {
                        var lambda = arguments[i];
                        try { xhr2 = lambda(); break; } catch (e) { }
                    }
                    return xhr2;
                },
                init: function () {
                    return this.tryList(
                        function () { return new ActiveXObject('MSXML2.XMLHttp.6.0'); },
                        function () { return new ActiveXObject('MSXML2.XMLHttp.3.0'); },
                        function () { return new XMLHttpRequest(); },
                        function () { return new ActiveXObject('MSXML2.XMLHttp.5.0'); },
                        function () { return new ActiveXObject('MSXML2.XMLHttp.4.0'); },
                        function () { return new ActiveXObject('Msxml2.XMLHTTP'); },
                        function () { return new ActiveXObject('MSXML.XMLHttp'); },
                        function () { return new ActiveXObject('Microsoft.XMLHTTP'); }
                        ) || null;
                },
                post: function (sUrl, sArgs, bAsync, fCallBack, errmsg) {
                    var xhr2 = this.init();
                    xhr2.onreadystatechange = function () {
                        if (xhr2.readyState == 4) {
                            if (xhr2.responseText) {
                                if (fCallBack.constructor == Function) { fCallBack(xhr2); }
                            } else {
                                //alert(errmsg);
                            }
                        }
                    };
                    xhr2.open('POST', encodeURI(sUrl), bAsync);
                    xhr2.setRequestHeader('Content-Length', sArgs.length);
                    xhr2.setRequestHeader('Content-Type', 'application/x-www-form-urlencoded');
                    xhr2.send(sArgs);
                },
                get: function (sUrl, bAsync, fCallBack, errmsg) {
                    var xhr2 = this.init();
                    xhr2.onreadystatechange = function () {
                        if (xhr2.readyState == 4) {
                            if (xhr2.responseText) {
                                if (fCallBack.constructor == Function) { fCallBack(xhr2); }
                            } else {
                                alert(errmsg);
                            }
                        }
                    };
                    xhr2.open('GET', encodeURI(sUrl), bAsync);
                    xhr2.send('Null');
                }
            }




            function SetSearchLink(item) {

                var url = "../journal/recordsearchinformation";
                var skid = $(":hidden[id$=HiddenField_SKID]").val();
                var args = "skid=" + skid;
                url = url + "?" + args + "&urllink=" + item;
                window.setTimeout("showSearchUrl('" + url + "')", 300);
            }

            function showSearchUrl(url) {
                var callback2 = function (xhr2) { }

                ajax2.get(url, true, callback2, "try");
            }

        </script>





<meta name="title" content="Synthesis of Fluorinated Heterobicyclic Nitrogen Systems Containing 1,2,4-Triazine Moiety as CDK2 Inhibition Agents" />
<meta name="keywords" content="Synthesis,Fluoroheterobicyclic Nitrogen,CDK2 Inhibition,Anti-Tumor Activity" />
<meta name="description" content="Discover new fluorine-substituted heterobicyclic nitrogen systems with potential anti-tumor activity. Synthesized through reactions with α,β–bifunctional compounds, these compounds were characterized using UV, IR, 1H/13C-NMR, and mass spectrometry. Explore their CDK2 inhibiting activity and DNA damage potential." />
<meta name="citation_journal_title" content="International Journal of Organic Chemistry" />
<meta name="citation_publisher" content="Scientific Research Publishing" />
<meta name="citation_authors" content="Mohammed Saleh Tawfik Makki;Reda Mohammdy Abdel-Rahman;Faisal Mohammed Aqlan" />
<meta name="citation_author" content="Mohammed Saleh Tawfik Makki" />
<meta name="citation_author" content="Reda Mohammdy Abdel-Rahman" />
<meta name="citation_author" content="Faisal Mohammed Aqlan" />
<meta name="citation_title" content="Synthesis of Fluorinated Heterobicyclic Nitrogen Systems Containing 1,2,4-Triazine Moiety as CDK2 Inhibition Agents" />
<meta name="citation_volume" content="5" />
<meta name="citation_date" content="2015-07-21" />
<meta name="citation_year" content="2015" />
<meta name="citation_doi" content="10.4236/ijoc.2015.53020" />
<meta name="citation_issnPrint" content="2161-4687" />
<meta name="citation_issnOnline" content="2161-4695" />
<meta name="citation_abstract" content="New fluorine substituted heterobicyclic nitrogen system as imidozolopyrimidines (2,3), pyrimido- 1,2,4-triazinones (4-7), 1,2,4-triazinyl-1,2,4-triazine (12-16), 1,2,4-triazinyl-1,2,4-triazinones (14-17) and substituted thiobarbituric acids (19-20), have been synthesized using the reaction of 3- amino-5,6-di (4&#39;-fluorophenyl)-1,2,4-triazine (1) with α,β–bifunctional compounds. Structures of the title compounds were characterized by UV, IR, 1H/13C-NMR and mass spectrometric method. The studied compounds were tested for CDK2 inhibiting activity in DNA damage, as well as in vitro anti-tumor activity." />
<meta name="citation_publication_date" content="2015/7/21" />
<meta name="citation_pdf_url" content="https://www.scirp.org/pdf/IJOC_2015092816192965.pdf" />
<meta name="fulltext_pdf" content="https://www.scirp.org/pdf/IJOC_2015092816192965.pdf" />
<meta name="citation_abstract_html_url" content="https://www.scirp.org/journal/paperabs?paperid=60000" />
<meta name="citation_fulltext_html_url" content="https://www.scirp.org/journal/paperinformation?paperid=60000" />
<meta name="fulltext_html" content="https://www.scirp.org/journal/paperinformation?paperid=60000" />
<meta name="citation_xml_url" content="https://www.scirp.org/xml/60000.xml" />
<meta name="fulltext_xml" content="https://www.scirp.org/xml/60000.xml" />
<meta name="citation_issue" content="3" />
<meta name="citation_online_date" content="2015/7/21" />
<meta name="citation_firstpage" content="200" />
<meta name="citation_lastpage" content="211" />

<meta name="dc.title" content="Synthesis of Fluorinated Heterobicyclic Nitrogen Systems Containing 1,2,4-Triazine Moiety as CDK2 Inhibition Agents" />

<meta name="dc.creator" content="Mohammed Saleh Tawfik Makki" />
<meta name="dc.creator" content="Reda Mohammdy Abdel-Rahman" />
<meta name="dc.creator" content="Faisal Mohammed Aqlan" /><meta name="dcterms.issued" content="2015-07-21" />
<meta name="dc.description" content="New fluorine substituted heterobicyclic nitrogen system as imidozolopyrimidines (2,3), pyrimido- 1,2,4-triazinones (4-7), 1,2,4-triazinyl-1,2,4-triazine (12-16), 1,2,4-triazinyl-1,2,4-triazinones (14-17) and substituted thiobarbituric acids (19-20), have been synthesized using the reaction of 3- amino-5,6-di (4&#39;-fluorophenyl)-1,2,4-triazine (1) with α,β–bifunctional compounds. Structures of the title compounds were characterized by UV, IR, 1H/13C-NMR and mass spectrometric method. The studied compounds were tested for CDK2 inhibiting activity in DNA damage, as well as in vitro anti-tumor activity." />
<meta name="dc.source" content="International Journal of Organic Chemistry" />
<meta name="dc.format" content="text/html" />
<meta name="dc.publisher" content="Scientific Research Publishing" />
<meta name="dc.date" content="2015-07-21" />
<meta name="dc.type" content="Article" />
<meta name="dc.identifier" content="doi:10.4236/ijoc.2015.53020" />
<meta name="dc.language" content="en" />
<meta name="dc.issued" content="2015-07-21" />
<meta name="prism.issnPrint" content="2161-4687" />
<meta name="prism.issnOnline" content="2161-4695" />
<meta name="prism.publicationName" content="International Journal of Organic Chemistry" />
<meta name="prism.publicationDate" content="2015-07-21" />
<meta name="prism.volume" content="5" />
<meta name="prism.number" content="3" />
<meta name="prism.section" content="Article" />
<meta name="prism.startingPage" content="200" />
<meta name="prism.doi" content="10.4236/ijoc.2015.53020" />
<meta name="Author" content="Scientific Research Publishing" />
<meta name="dc.rights" scheme="DCTERMS.URI" content="http://creativecommons.org/licenses/by/4.0/" />
<meta name="dc.rights" content="(c) 2015 by author(s) and Scientific Research Publishing Inc." /></head>
<body>
    <form method="post" action="./paperinformation?paperid=60000" id="form1">
<div class="aspNetHidden">
<input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="" />
<input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="" />
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" />
</div>

<script type="text/javascript">
//<![CDATA[
var theForm = document.forms['form1'];
if (!theForm) {
    theForm = document.form1;
}
function __doPostBack(eventTarget, eventArgument) {
    if (!theForm.onsubmit || (theForm.onsubmit() != false)) {
        theForm.__EVENTTARGET.value = eventTarget;
        theForm.__EVENTARGUMENT.value = eventArgument;
        theForm.submit();
    }
}
//]]>
</script>


<script src="/WebResource.axd?d=nbhKwR1Oxldo88IqKSPXdjHZtvJJs8lUIgW_Px6JXqsU14OEPTlsfYc1iFwkKjKQFuU0A5B023C_t5MMw-na4wjNK5fA91XK5AnyAlxXUms1&amp;t=637461269481343508" type="text/javascript"></script>


<script src="/ScriptResource.axd?d=mQBWVXSQvywKG0wBehnziCfcFgrNM4av8J0HgAKchKpJWZgg0r5Xs80ubwoKV7AD4O3M7796UejusG1WTVZtPN-HH1OVRu1qdJQeBwraVdFzAa5uhBZ1xzdJTuUJ8jxsoiOWVycBi-EqnhEbamCkYQaM6illNzJ1XnAiTPTM4lY1&amp;t=2fe674eb" type="text/javascript"></script>
<script src="/ScriptResource.axd?d=pGcs6pxlC35gRrkU-shVxpWZoCnFV8u84WJcSmiMxzu6Ck0U5QE3O35G5nj5IpjUnOLUbKfyeJAPgY7NM9wyaeXbLGnLaq6HMCjKil7Fa01s2Wj_tz_O7lREhqN2werxnA_Essq6sQ-jYGcvTtSwHlt3-Ow6qYGLVobZINxBRUIQLDoT0WA7vd3tQitIrOyo0&amp;t=2fe674eb" type="text/javascript"></script>
<div class="aspNetHidden">

	<input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="D21FCB0F" />
	<input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="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" />
</div>


        <script type="text/javascript">
//<![CDATA[
Sys.WebForms.PageRequestManager._initialize('ctl00$ScriptManager1', 'form1', [], [], [], 90, 'ctl00');
//]]>
</script>


        




<header>
    <div class="container row clearfix center-block">
        <div class="col-sm-8 col-xs-9 column" style="padding: 10px 0;"><a href="//www.scirp.org" title="SCIRP - An Academic Publisher" target="_blank">
            <img src="../images/SRP_logo.svg" height="50"></a>
        </div>
        <div class="col-sm-3 col-xs-3 column text-center" style="padding: 20px 0;">
            <a href="/journal/openaccess" title="OPEN ACCESS" target="_blank">
                <img src="../images/Open-Access.svg" height="30"></a>
        </div>
        <div class="col-sm-1 col-xs-2 column visible-lg visible-md visible-sm " style="padding: 20px 0;">
            <a href="https://papersubmission.scirp.org/login.jsp" target="_blank" title="Login">
                <button type="button" class="btn btn-default btn-xs" style="font-size: 18px; font-family: Arial, Helvetica, sans-serif; padding: 0 15px; border: #2f2f2f 1px solid; border-radius: 5px; float: right;">Login</button></a>
        </div>
    </div>
</header>


<nav class="navbar navbar-inverse" role="navigation" style="margin-bottom: 10px;">
    <div class="container container-fluid center-block">
        <div class="navbar-header">
            <a href="https://papersubmission.scirp.org/login.jsp" target="_blank" ><button type="button" class="btn btn-xs btn-default navbar-brand visible-xs" style="width: 80px; height: 30px; font-size: 18px; font-family: Arial, Helvetica, sans-serif; margin: 10px; padding: 0 15px; border-radius: 5px;">Login</button></a>
            <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#example-navbar-collapse">
                <span class="sr-only">切换导航</span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
                <span class="icon-bar"></span>
            </button>
        </div>
        




<div class="collapse navbar-collapse" id="example-navbar-collapse">
    <ul class="nav navbar-nav" style="font-size: 18px;">
        <li><a href="../" target="_top">Home</a></li>
        <li><a href="../journal/articles" target="_top">Articles</a></li>
        <li><a href="../journal/" target="_top">Journals</a></li>
        <li><a href="../book/" target="_top">Books</a></li>
        <li><a href="../news/" target="_top">News</a></li>
        <li><a href="../aboutus/" target="_top">About</a></li>
        <li><a href="../author/" target="_top">Services</a></li>
        <li><a href="//papersubmission.scirp.org/login.jsp?sub=true" target="_blank">Submit</a></li>
    </ul>
</div>


    </div>
</nav>



        <div class="container-fluid link_here" style="margin-bottom: 15px;">
            <div class="row container center-block clearfix" style="padding: 0;">

                <!--页面导航栏-->
                <div class="col-md-7 column" style="padding: 0;">
                    
<ul class="breadcrumb">
        <li><i class="fa fa-home" style="color: #d71318;"></i>&nbsp;&nbsp;<a href="../index">Home</a></li>
        <li><a href="index">Journals</a></li>
        <li class="active">Article</li>
    </ul>

                </div>

                <!--搜索框-->
                <div class="col-md-5 column">
                    <div class="" style="padding: 5px 0;">
                        <div id="UserControl_search_common_Panel2" onkeypress="javascript:return WebForm_FireDefaultButton(event, &#39;UserControl_search_common_btnSearch2&#39;)">
	
    <div class="form-inline search2">
        <input name="ctl00$UserControl_search_common$TextBox_searchCode2" type="text" value="Search Title, Keywords, Author, etc." id="UserControl_search_common_TextBox_searchCode2" class="input2" onFocus="return ClearSearchCondition2();" onBlur="return ShowSearchCondition2();" onkeypress="if(event.keyCode==13){document.all.UserControl_search_common_btnSearch2.focus();document.all.UserControl_search_common_btnSearch2.click();   return   false;}" style="height: 28px;" />
        <button class="btn-md btn_or" type="button">
          <input type="submit" name="ctl00$UserControl_search_common$btnSearch2" value=" " id="UserControl_search_common_btnSearch2" style="width:25px; height:25px; background: none; border:none;background-image: url(../Images/search001.png);  " />  
        </button>
        

    </div>

    <script type="text/javascript">
        function ClearSearchCondition2() {
            var text2 = document.getElementById('UserControl_search_common_TextBox_searchCode2').value;
            if (text2 == "Search Title, Keywords, Author, etc.")
            { document.getElementById('UserControl_search_common_TextBox_searchCode2').value = ""; }
        }

        function ShowSearchCondition2() {
            var text2 = document.getElementById('UserControl_search_common_TextBox_searchCode2').value;
                if (text2 == "")
                { document.getElementById('UserControl_search_common_TextBox_searchCode2').value = "Search Title, Keywords, Author, etc."; }
            }


            function checkLog() {

                var keywords = document.getElementById("UserControl_search_common_TextBox_searchCode2").value;  //关键字

            if (trim(keywords) == "") {
                alert('Please enter keywords!');
                return false;
            }

            if (trim(keywords) == "Search Title, Keywords, Author, etc.") {
                alert('Please enter keywords!');
                return false;
            }

            return true;
        }

        //除去左右空格
        function trim(string) {
            return string.replace(/(^\s*)|(\s*$)/g, "");
        }


    </script>

</div>

                    </div>
                </div>

            </div>
        </div>


        <div class="container">
            <div class="row clearfix">

                <div class="col-md-9 column col-md-push-3">
                    <div class="clearfix con_main" style="margin-bottom: 10px; padding-left: 15px; padding-right: 15px;">
                        
       

<div id="JournalInfor_div_nav_journal" class="column up_link1 clearfix" style="padding: 0;">
            <div class="col-md-9 col-sm-8 txt7">
                <a href="journalarticles?journalid=527" title="International Journal of Organic Chemistry">
                    International Journal of Organic Chemistry</a> &gt; <a href="home?issueid=6736#60000">Vol.5 No.3, September 2015</a>
            </div>
            </div>

    <div id="JournalInfor_div_paper" class="articles_main">
            <div class="art_title" style="text-align:left;">
                Synthesis of Fluorinated Heterobicyclic Nitrogen Systems Containing 1,2,4-Triazine Moiety as CDK2 Inhibition Agents <span id="JournalInfor_reviewpaper_show" style="color:gray;font-weight:normal;Display:None;">()</span>
            </div>
            
        <div style="float: left; width: 100%; margin-top: 5px; margin-bottom: 10px;">
                <a href='articles?searchcode=Mohammed+Saleh+Tawfik++Makki&searchfield=authors&page=1' target='_blank'>Mohammed Saleh Tawfik  Makki</a><sup>*</sup>, <a href='articles?searchcode=Reda+Mohammdy++Abdel-Rahman&searchfield=authors&page=1' target='_blank'>Reda Mohammdy  Abdel-Rahman</a><sup></sup>, <a href='articles?searchcode=Faisal+Mohammed++Aqlan&searchfield=authors&page=1' target='_blank'>Faisal Mohammed  Aqlan</a><sup></sup> 
                <br />
                <span id="JournalInfor_div_affs"><a href='articles?searchcode=Department+of+Chemistry%2c+Faculty+of+Science%2c+King+Abdulaziz+University%2c+Jeddah%2c+Saudi+Arabia&searchfield=affs&page=1' target='_blank'>Department of Chemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia</a>.<br /></span>
               
                <span id="JournalInfor_showDOI" style="clear: left;"><b>DOI: </b><a href="http://dx.doi.org/10.4236/ijoc.2015.53020"
                    target="_blank" onclick='SetNum(60000)'>10.4236/ijoc.2015.53020</a></span>&nbsp;&nbsp;
                      
                <a href="//www.scirp.org/pdf/IJOC_2015092816192965.pdf" target="_blank" style="font-size: 14px; font-weight: bold;" onclick='SetNum(60000)'>
                    PDF</a>
            &nbsp;&nbsp;&nbsp;<span style="font-size: 14px; font-weight: bold;"><a href='//www.scirp.org/journal/paperinformation?paperid=60000' target='_blank'>HTML</a></span>&nbsp;&nbsp;<span style="font-size: 14px; font-weight: bold;"> <a href='//www.scirp.org/xml/60000.xml' target='_blank' onclick='SetNum(60000)' >XML</a></span>&nbsp;&nbsp;
                <span style="font-weight: bold; color: Red;">
                    5 191</span>
                <span style="color: #535353;">Downloads</span>&nbsp;&nbsp;<span style="font-weight: bold; color: Red;">
                    6 625</span>
                <span style="color: #535353;">Views</span>&nbsp;&nbsp;
                <span id="JournalInfor_span_citations" style="Display:inline;"><a href='papercitationdetails?paperid=60000&JournalID=527' target="_blank"><span style="text-decoration: underline;">Citations</span></a></span>
            </div>

            <div style="margin-bottom: 10px;">
                <p style="font-weight: bold; font-size: 16px;"><a name="abstract" style="color: #2f2f2f;">Abstract</a></p>
                <p style="text-align:left;">New fluorine substituted heterobicyclic nitrogen system as imidozolopyrimidines (2,3), pyrimido- 1,2,4-triazinones (4-7), 1,2,4-triazinyl-1,2,4-triazine (12-16), 1,2,4-triazinyl-1,2,4-triazinones (14-17) and substituted thiobarbituric acids (19-20), have been synthesized using the reaction of 3- amino-5,6-di (4'-fluorophenyl)-1,2,4-triazine (1) with <em>α</em>,<em>β</em>–bifunctional compounds. Structures of the title compounds were characterized by UV, IR, <sup>1</sup>H/<sup>13</sup>C-NMR and mass spectrometric method. The studied compounds were tested for CDK2 inhibiting activity in DNA damage, as well as<em> in vitro</em> anti-tumor activity.</p>
            </div>

            <div id="JournalInfor_div_showkeywords" style="margin-bottom: 10px;">
                <p style="font-weight: bold; font-size: 16px;">Keywords</p>
                <p><a href='articles?searchcode=Synthesis&searchfield=keyword&page=1' target='_blank'>Synthesis</a>, <a href='articles?searchcode=+Fluoroheterobicyclic+Nitrogen&searchfield=keyword&page=1' target='_blank'> Fluoroheterobicyclic Nitrogen</a>, <a href='articles?searchcode=+CDK2+Inhibition&searchfield=keyword&page=1' target='_blank'> CDK2 Inhibition</a>, <a href='articles?searchcode=+Anti-Tumor+Activity&searchfield=keyword&page=1' target='_blank'> Anti-Tumor Activity</a> </p>
            </div>

            <div style="margin-bottom: 10px;">
                <p style="font-size: 16px; font-weight: bold;">Share and Cite: </p>
                <div id="JournalInfor_div_share">   
                  <!-- AddToAny BEGIN -->

<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_sina_weibo"></a>
<a class="a2a_dd" href="https://www.addtoany.com/share"></a>
</div>
<script type="text/javascript" async src="https://static.addtoany.com/menu/page.js"></script>
<!-- AddToAny END -->
                    

                                      
                </div>
                <div style="margin-top: 10px; text-align:left;">
                    Makki, M. , Abdel-Rahman, R.  and Aqlan, F.   (2015) Synthesis of Fluorinated Heterobicyclic Nitrogen Systems Containing 1,2,4-Triazine Moiety as CDK2 Inhibition Agents. <i>International Journal of Organic Chemistry</i>, <b>5</b>, 200-211. doi: <a href='http://dx.doi.org/10.4236/ijoc.2015.53020' target='_blank' onclick='SetNum(60000)'>10.4236/ijoc.2015.53020</a>.
                </div>
            </div>
            <div style="margin-top:10px;" id="htmlContent">
                 
<p></p>
<p class="E-Title1">1. Introduction</p>
<p>1,2,4-triazines and their condensed analogues have shown to display wide-ranging applications in medicinal and pharmaceutical chemistry. The NCNN group of 1,2,4-triazine ring is an essential part in various biological activities. Tirapazamine as antitumor [1] , Lamotrigine as anti-epileptic drug [2] , and fused 1,2,4-triazines as antimicrobial [3] -[5] , anti HIV [6] antimycobacterial [7] , antiviral [8] [9] , anxiolytic [10] and antidepressant [11] agents are already reported in literature. Heterobicyclic nitrogen systems containing 1,2,4-triazine moiety have also shown anti-HIV and anticancer activities [12] -[16] . However, introduction of fluorine atoms to these bioactive heterocycles often improves their pharmacological properties mainly due to increased membrane permeability, enhanced hydrophobic bonding and stability against metabolic transformation owing to the strength of the C-F bond [17] -[21] . Also, introduction of fluorine in these heterobicyclic systems exhibited enhanced anti-tumor activity [20] . The search for novel cancer treatment has however entered a new post-genomic era and the emphasis now is on influencing cell signaling mechanisms such as those triggered by kinases<sup> </sup>[22] where selective inhibition of the Kinome constituents and related signaling proteins has opened up a diversity of new drug targets.</p>
<p>Cyclin-Dependent Kinases (CDKs) are families of serine/threonine kinases that play a well-established role in the regulation of the eukaryotic cell division cycle and have also been implicated in the control of gene transcription and other processes [23] . Dysregulation of cell cycle in cancer cells has provided a rationale for the development of small molecule inhibitors of CDK1 as novel anticancer drugs. It was believed that CDK2 was the master regulator of S phase entry. Gene knockout mouse studies of cell cycle regulators revealed that CDK2 is dispensable for S phase inhibition and progression whereby CDK1 can compensate for the loss of CDK2 and the latter was found to be involved in cell cycle independent functions such as DNA damage repair [24] .</p>
<p>Rational approaches to the design of fluorine-containing potential inhibitors associated with the strategic placement of fluorine in these molecules led us to design CDK2 inhibitors as possible anti-cancer agents. The aim of the present work is to synthesize and develop fluorinated fused and/or isolated heterobicyclic nitrogen systems, derived from the interaction between 3-amino,6-(4′-fluorophenyl)-1,2,4-triazines (1) and α, β-bifunc- tional oxygen, sulfur, halogen and nitrogen compounds. In this work, we evaluate the protein kinase inhibiting and cytotoxic activity of fluorinated heterobicyclic systems containing 1,2,4-triazine moiety.</p>
<p class="E-Title1">2. Experimental</p>
<p class="E-Title2">2.1. Chemicals and Methods</p>
<p>Melting points were determined using an electrothermal Bibby Stuart Scientific melting point apparatus and are uncorrected. The infrared (IR) spectra were recorded on a Perkin-Elmer FT-IR infrared spectrophotometer using the KBr pellet technique. Electronic absorption spectra were recorded in DMF using a Shimadzu UV-Visible 1650 PC spectrophotometer. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker DPX-400 FT NMR spectrometer using tetramethylsilane ( internal standard DMSO-d<sub>6</sub>) as a solvent (Chemical shifts in δ, ppm). <sup>19</sup>F NMR Spectra were determined at 84.25 MHz using hexafluorobenzene as a solvent. Splitting patterns were designated as follows: s: singlet; m: multiplet. Mass spectra were measured on a GCMS-Q 1000 Ex spectrometer. Elemental analyses were performed on a 2400 Perkin Elmer Series 2 analyzer and the found values were within &plusmn;0.4% of the theoretical values. Follow up of the reactions and checking the homogeneity of the compounds were made by TLC on silica gel-protected aluminum sheets (Type 60 F254, Merck) and the spots were detected by exposure to UV-lamp.</p>
<p class="E-Title3">2.1.1. 3-Amino-5,6-di(4׳-fluorophenyl)-1,2,4-triazine (1)</p>
<p>A mixture of 4,4׳-bifluorobenzil (0.01 mol) and aminoguanidine bicarbonate (0.01 mol) in n-butanol [28] was refluxed for 4 h. The solid obtained after cooling the mixture was filtered and crystallized from ethanol to give orange crystals, yield 75%, m.p. 208˚C - 209˚C. IR (n/cm<sup>−1</sup>): 3200 (NH<sub>2</sub>), 1620 (deformation, NH<sub>2</sub>), 1600 (C=N), 1250 (C-F) and 880, 820 (p-substituted phenyl). <sup>1</sup>H-NMR (DMSO d<sub>6</sub>) δ: 2.89 - 2.51 (br. s, 2H, NH<sub>2</sub>), 7.31 - 7.39, 7.39 - 7.44 (each m, 8H, aromatic protons), 7.0 - 6.61 (m). <sup>13</sup>C-NMR (DMSO d<sub>6</sub>) δ: 164,156, 148, 136 - 131, 129.8 - 127.7. Anal. Calcd: C, 63.15; H, 3.40; N, 21.67; F, 11.76% for C<sub>17</sub>H<sub>5</sub>N<sub>5</sub>F<sub>2</sub> (323). Found: C, 62.98; H, 3.25; N, 21.50; and F, 11.6%.</p>
<p class="E-Title3">2.1.2. 3-Amino-5,7-di(4'-fluorophenyl)imidazo[3,2-b][1,2,4-]triazine (2)</p>
<p>A mixture of 1 (0.01 mol) and chloroacetonitrile (0.01 mol) in DMF was refluxed for 4 h. The solid obtained on cooling the reaction mixture was filtered and crystallized from dioxan to give 2 as yellowish crystals, yield 70%, m.p. 141˚C - 142˚C. IR (n/cm<sup>−1</sup>): 3350, 3228 (NH<sub>2</sub>, NH), 31.86 (aromatic CH), 1623 (deformation NH<sub>2</sub>), 1601, 1517 (C=N), 1350 (NCN), 1226 (C-F). <sup>1</sup>H-NMR (DMSO d<sub>6</sub>) δ: 7.89, 7.4, 7.37, 7.28, 7.24, 7.166, 7.00 and 6.94 (m, 8H, aromatic protons), 6.89, 6.717 (d, d of H adjacent of F), 4.01 - 3.97 (s, 2H, NH<sub>2</sub>). <sup>13</sup>C-NMR (DMSO d<sub>6</sub>) δ: 164, 155, 147, 132, 131 - 130.4, 115, 114, 77.88 - 77.46, 59.68. M/S (Int. %): 323 (8.89), 282 (33.01), 214 (100). Anal. Calcd: C, 62.96; H, 3.08; N, 17.28; F, 11.72%; for C<sub>17</sub>H<sub>10</sub>N<sub>4</sub>F<sub>2</sub>O (324). Found: C, 62.79; H, 2.88; N, 17.15; and F, 11.55%.</p>
<p class="E-Title3">2.1.3. 6,7-Di(4'-fluorophenyl)-2,3-dihydro-3-oxo-imidazo[3,2-b][1,2,4-]triazine(3)</p>
<p>A mixture of 1 (0.01 mol) and monochloroacetic acid (0.01 mol) in DMF was heated for 15 min. and then left to cool at room temperature. The solid obtained was filtered and crystallized from dioxan to give 3 as faint yellowish crystals, yield 65%, m.p. 193˚C - 194˚C. IR (n/cm<sup>−1</sup>): 3090 (ArCH), 1640 (C=O ↔ C-OH), 1480 (deformation CH<sub>2</sub>), 2950 (aliphatic CH), 1350 (NCN), and 1227 (C-F). <sup>1</sup>H-NMR (DMSO d<sub>6</sub>) δ: 7.61, 7.41, 7.39, 7.38, 7.32, 7.31, 7.306 and 7.301 (m, 8H, aromatic protons), 7.29 (s, 1H, CH=), 6.98 - 6.97, 6.95 and 6.54 (d, d of H adjacent of F), 2.52 - 2.51 (s, 2H, CH<sub>2</sub>). <sup>13</sup>C-NMR (DMSO d<sub>6</sub>) δ: 164, 155, 147, 132.1, 131 - 130.4, 115, 114 and 77.77 - 77.34. Anal. Calcd: C, 62.96; H, 3.08; N, 17.28; F, 11.72%; for C<sub>17</sub>H<sub>10</sub>N<sub>4</sub>F<sub>2</sub>O (324). Found: C, 62.76; H, 2.91; N, 17.01; and F, 11.55%.</p>
<p class="E-Title3">2.1.4. 7,8-Di(4'-fluorophenyl)-2,3-dihydro-pyrimido[3,2-b][1,2,4-]triazin-2,4-dione (4)</p>
<p>A mixture of 1 (0.01 mol) and diethylmalonate (0.01 mol) in THF was refluxed for 4 h. On cooling the reaction mixture, a yellowish solid separated which was crystallized from THF to give 4 as yellow crystals, yield 72%, m.p. 199˚C - 200˚C. UV (EtOH): λ<sub>max</sub> 346 nm. IR (n/cm<sup>−1</sup>): 3091 (Ar-CH), 2980 (aliphatic CH), 1680, 1650 (2C=O), 1576 (C=N) 1492 (deformation CH<sub>2</sub>), 1381 (NCN), 1225 (C-F), 919, 867 and 815 (p-substituted phenyl). <sup>1</sup>H-NMR (DMSO d<sub>6</sub>) δ: 7.69 - 7.29 (m, 8H, aromatic protons), 6.98 - 6.67 (d, d, s, H adjacent F), 3.65 - 3.613 (t, 2H, CH<sub>2</sub>). <sup>13</sup>C-NMR (DMSO d<sub>6</sub>) δ: 164.01, 162.93, 155, 147.86, 132.18, 131.83 - 131.29, 130.54, 130.49, 115.03, 114.88, 77.97 - 77.54, 67.22 and 40.03-39.33. Anal. Calcd: C, 61.36; H, 2.84; N, 15.90; and F, 10.79%; for C<sub>18</sub>H<sub>10</sub>N<sub>4</sub>F<sub>2</sub>O<sub>2</sub> (324). Found: C, 61.86; H, 2.56; N, 15.78; and F, 10.58%.</p>
<p class="E-Title3">2.1.5. 4-Amino-2-oxo-7,8-di(4'-fluorophenyl)pyrimido[3,2-b][1,2,4-]triazine (6)</p>
<p>A mixture of 1 (0.01 mol) and ethyl cyanoacetate (0.01 mol) in THF was refluxed for 4 h. The solid obtained after cooling the reaction mixture was filtered and crystallized from ethanol to give deep-yellow crystals, yield 65%, m.p. 198˚C - 200˚C. UV (EtOH): λ<sub>max</sub> 346 nm. IR (n/cm<sup>−1</sup>): 3300 (NH<sub>2</sub>), 1670, 1610 (deformation NH<sub>2</sub>), 1229 (C-F), 828 and 810 (p-substituted ring). <sup>1</sup>H-NMR (DMSO d<sub>6</sub>) δ: 7.40 - 7.29 (m, 8H, aromatic protons), 6.971 (s, 1H, =CH cyclic), 6.96 - 6.69 (d, d, s, H adjacent of F), 3.62 (s, 2H, NH<sub>2</sub>). <sup>13</sup>C-NMR (DMSO d<sub>6</sub>) δ: 164.01, 154.9, 147.8, 132.16, 131.81 - 130.48, 115, 114.8, 77.78 - 77.57 and 67.21. M/S (Int. %): 351 (8.18), 307 (28.13), 214 (100). Anal. Calcd: C, 61.53; H, 3.13; N, 19.94; and F, 10.82%; for C<sub>18</sub>H<sub>11</sub>N<sub>5</sub>F<sub>2</sub>O (351). Found: C, 61.33; H, 3.02; N, 19.58; and F, 10.69%.</p>
<p class="E-Title3">2.1.6. 7,8-Di(4'-fluorophenyl)-3-(arylidene)pyrimido[3,2-b][1,2,4-]triazin-2,4-dione (5)</p>
<p>A mixture of 4 (0.01 mol) and p-chlorobenzaldehyde (0.01mol) in EtOH was refluxed for 1h and then allowed to cool at room temperature. The solid thus obtained was filtered and crystallized from ethanol to give 5 as yellowish crystals, yield 78%, m.p. 208˚C - 209˚C. IR (n/cm<sup>−1</sup>): 3024 (Ar-CH), 1680, 1660 (2C=O), 1610 (C=C), 1576 (C=N), 1382 (NCN), 1227 (C-F), 820 and 815 (p-substituted ring). <sup>1</sup>H-NMR (DMSO d<sub>6</sub>) δ: 9.9 (s, 1H, CH=), 7.76 - 7.75, 7.70 - 7.60 (m, 8H, aromatic protons), 7.35 - 7.20 (m, 4H, aryl protons), and 6.95 - 6.37 (d, d, s, H of adjacent F). Anal. Calcd: C, 63.15; H, 2.73; N, 11.78; F, 8.0; and Cl, 7.57%; for C<sub>25</sub>H<sub>13</sub>N<sub>4</sub>F<sub>2</sub>ClO<sub>2</sub> (475). Found: C, 62.88; H, 2.60; N, 11.58; F, 7.69; and Cl, 7.49%.</p>
<p class="E-Title3">2.1.7. 7,8-Di(4'-fluorophenyl)-4-arylidino-pyrimido[3,2-b][1,2,4-]triazin-2-one(7)</p>
<p>A mixture of 6 (0.01 mol) and p-chlorobenzaldehyde (0.01 mol) in EtOH was refluxed for 1h and subsequently left to cool at room temperature. A solid appeared which was filtered and crystallized from ethanol to give yellow crystals, yield 82%, m.p. 212˚C - 214˚C. IR (n/cm<sup>−1</sup>): 3092 (Ar-CH), 1668 (C=O), 1602 (C=N), 1226 (C-F), 919, 858 and 815 (p-substituted ring). <sup>1</sup>H-NMR (DMSO d<sub>6</sub>) δ: 7.85 - 7.81 (m, 4H, aromatic H), 7.40 - 7.28 (m, 8H, aromatic H), 6.99 - 6.97 (d, d, s, H of adjacent F), 6.838 (1H, CH=N). <sup>13</sup>C-NMR (DMSO d<sub>6</sub>) δ: 163.96, 161.24, 154.92, 147.68, 132.32, 131.95, 130.58 - 130.52, 115.03, 115.02, 114.89, 114.88, 78.25 - 77.81 and 40.16. Anal. Calcd: C, 63.29; H, 2.95; N, 14.76; F, 8.01; and Cl, 7.59%; for C<sub>25</sub>H<sub>14</sub>N<sub>5</sub>F<sub>2</sub>ClO (474). Found: C, 62.98; H, 2.75; N, 14.49; F, 7.78; and Cl, 7.38%.</p>
<p class="E-Title3">2.1.8. Ethyl 3-(carboxyamino)-5,6-di(4׳-fluorophenyl)-1,2,4-triazine (8)</p>
<p>A mixture of 1 (0.01 mol) and ethyl chloromethanoate (0.01 mol) in benzene-TEA mixture was refluxed for an hour. The solid obtained after cooling the reaction mixture was filtered and crystallized from THF to give 8 as faint yellow crystals, yield 60%, m.p. 178˚C - 180˚C. IR (n/cm<sup>−1</sup>): 3300 (NH), 3080 (Ar-CH), 2980 (R-CH), 1676 (C=O), 1483 (deformation CH<sub>3</sub>), 1381 (NCN), 1226 (C-F), 1010 (O-C-O), 840, and 815 (p-substituted ring). <sup>1</sup>H-NMR (DMSO d<sub>6</sub>) δ: 8.87 (s, 1H, NH), 7.68 - 7.40, 7.39 - 7.29 (each m, 8H, aromatic H), 7.03 - 7.00, 6.94 - 6.82 (d, d, s, H adjacent F), 4.20 (t, 2H, CH<sub>2</sub>O), and 1.4 - 1.2 (s, 3H, CH<sub>3</sub>). <sup>13</sup>C-NMR (DMSO d<sub>6</sub>) δ: 164.87, 161.81, 160.98, 157.05, 147.64, 146.91, 141.26, 132.14, 132.08, 130.86 - 127.10, 115.40, 115.25, 114.96, 114.45, 78.46 - 78.03, 39.98, and 14.19. Anal. Calcd: C, 60.67; H, 3.93; N, 15.73 and F, 10.67%; for C<sub>18</sub>H<sub>14</sub>N<sub>4</sub>F<sub>2</sub>O<sub>2</sub> (356). Found: C, 60.41; H, 3.64; N, 15.61 and F, 10.55%.</p>
<p class="E-Title3">2.1.9. N<sup>4</sup>-(5’-6’-diaryl-1,2,4-triazin-3’-yl)semicarbazide (10)</p>
<p>A mixture of 8 (0.01 mol) and hydrazine hydrate (0.01 mol) in EtOH was refluxed for 2 h, and then cooled at room temperature. The solid obtained was filtered and crystallized from ethanol to give 10 as faint yellow crystals, yield 60%, m.p. 198˚C - 200˚C.</p>
<p>IR (n, cm<sup>−1</sup>): 3334, 3269 (NH, NH<sub>2</sub>), 3092(Ar-CH), 1660 (C=O), 1228 (C-F), 860 and 810 (p-substituted ring). <sup>1</sup>H-NMR (DMSo-d<sub>6</sub>): 8.8 (s, 1H, NH), 7.72-7.25 (m, 8H aromatic H), 6.98 - 6.67 (m, d, d, s, H, adjacent F) and 3.16 (s, 2H, NH<sub>2</sub>). <sup>13</sup>C-NMR(DMSO-d<sub>6</sub>): 164.02, 161.29, 155.02, 147.86, 132.17, 131,82, 131.35, 131.29, 130.54 - 130.49, 115.13, 115.02, 114.88, 77.94 - 77.53 and 40.14 - 39.19. Analy. Calcd.: C, 56.14; H, 3.50; N, 24.26 and F, 11.11%; for C<sub>16</sub>H<sub>12</sub>N<sub>6</sub>F<sub>2</sub>O (342). Found: C, 55.89; H, 3.35; N, 24.39; and F, 11.01%.</p>
<p class="E-Title3">2.1.10. N<sup>4</sup>-(5׳-6׳-Di(4׳-fluorophenyl)-1,2,4-triazin-3׳-yl)thiosemicarbazide (11)</p>
<p>A mixture of 1 (0.01 mol) and carbon disulfide (0.01 mol) in 1% KOH solution was stirred for 2 h at room temperature to give the intermediate 9. Now a mixture of 9 (0.01mol) and hydrazine hydrate (0.01mol) in EtOH was refluxed for 2 h and subsequently cooled in an ice-bath for few minutes to form a brownish yellow solid. The solid was filtered and crystallized from ethanol to give 11 as orange crystals, yield 78%, m.p. 203˚C - 204˚C. IR (n/cm<sup>−1</sup>): 3314, 3229, 3192 (NH, NH, NH). 1381 (NCN), 1225 (C-F), 1157 (C=S) and 850 (p-substituted ring). <sup>1</sup>H-NMR (DMSO-d<sub>6</sub>): 772 - 7.29 (m, 8H, aromatic H), 6.98 - 6.72 (m, d, d, s, H, adjacent F) and 3.14 (s, 2H, NH<sub>2</sub>). <sup>13</sup> C-NMR (DMSO-d<sub>6</sub>): 164.0, 162.2, 161.28, 154.98, 147.81, 132.21, 131.85 - 130.50, 115.03, 114.88, 78.04 - 77.61 and 40.02-39.19. Analy. Calcd: C, 53.63; H, 3.35; N, 23.46; and F, 10.61; S, 8.93%, for C<sub>16</sub>H<sub>12</sub>N<sub>6</sub>F<sub>2</sub>S (358), Found: C, 53.38; H, 3.20; N, 23.41; and F, 10.38; S, 8.78%.</p>
<p class="E-Title3">2.1.11. 5,6-Di(4׳-fluorophenyl)-3-(2׳,3׳-dihydro-3׳-oxo-1׳,2׳,4׳-triazol-4׳-yl)-1,2,4-triazine (12)</p>
<p>A mixture of 10 (0.5 g) and triethyl orthoformate (10 ml) was refluxed for 2h and then cooled at room temperature. The produced solid was filtered and crystallized from dioxan to give 12 as faint yellowish crystals, yield 65%, m.p. 190˚C - 192˚C. IR (n/cm<sup>−1</sup>): 3192 (NH), 1679 (C=O), 1572(C=N), 1382 (NCN),1227 (C-F), 880 and 816 (p-substituted ring). <sup>1</sup>H-NMR (DMSO-d<sub>6</sub>): 8.81 (s, 1H, NH), 7.62 - 7.27 (m, 8H, aromatic H), 6.966 - 6.92 (d, d, s, H, adjacent F) and 6.60 (s, 1H,CH=N):<sup>13</sup>CNMR (DMSO-d<sub>6</sub>): 164.02, 161.40, 154.9, 132.16, 131.28, 130.53 - 130.48, 115.02, 114.88 and 77.93 - 77.49. Analy. Calcd: C, 57.95; H, 2.84; N, 23.86; and F.10.79%, for C<sub>17</sub>H<sub>10</sub>F<sub>2</sub>O (352). Found: C, 57.55; H, 2.70; N, 23.59; and F, 10.61%.</p>
<p class="E-Title3">2.1.12. 5,6-Di(4׳-fluorophenyl)-3-(3׳-mercapto-5׳-hydroxy-1׳,2׳,4׳-triazol-4׳-yl)-1,2,4-triazine (13)</p>
<p>A mixture of 11 (0.01 mol) and carbon disulfide (0.01 mol) in dimethyl formamide was refluxed for 2 h. The reaction mixture was cooled in ice-bath to form a solid which was filtered and crystallized from ethanol to give 13 as orange crystals, yield 65%, m.p. 210˚C - 212˚C. IR (n/cm<sup>−1</sup>): 3259, 3192 (NH, NH), 1658 (C=O), 1389 (NCN), 1225 (C-F), 1156 (C=S), 880 and 829 (p-substituted ring). <sup>1</sup>H-NMR (DMSO-d<sub>6</sub>): 13.3, 12.8 (each s, NH, NH), 7.91 - 7.28 (m, 8H, aromatic H) and 6.98 - 6.69 (m, d, d, s, H adjacent F). <sup>13</sup>CNMR (DMSO-d<sub>6</sub>):195 (164.0), 161.28, 154.99, 147.83, 132.20 131.84, 131.29 - 130.49, 115.03, 114.88 and 78.01 - 77.58. Analy. Calcd: C, 53.12; H, 2.60; N, 21.87: F. 9.89; and S, 8.33%, for C<sub>17</sub>H<sub>10</sub>N<sub>2</sub>SO (384), Found: C, 52.89; H, 2.39; N, 21.55; F, 9.69; and S, 8.01%.</p>
<p class="E-Title3">2.1.13. 5,6-Di(4׳-fluorophenyl)-3-(6׳-methyl-3׳-hydroxy-5׳-oxo-1׳,2׳,4׳-triazin-4׳-yl)-1,2,4-triazine (14)</p>
<p>Equimolar mixture of 10 and sodium pyruvate in 5% NaOH solution (50 ml) was refluxed for 2 h, cooled then poured onto ice-HCl. The solid obtained was filtered and crystallized from ethanol to give 14 as faint yellow crystals, yield 65%, m.p. 213˚C - 214˚C. IR (n/cm<sup>−1</sup>): 3372, 3297 (OH+NH), 1700, 1626 (CO, CONH), 1567 (C=N), 1483 (deformation CH<sub>3</sub>) 1379 (NCN), 1224 (C-F), 1155 (C=S), 829 and 810 (p-substituted ring). <sup>1</sup>H-NMR (DMSO-d<sub>6</sub>): 13.481 (s, 1H, NH), 7.65, 7.41, 7.39, 7.22, 7.20, 7.19, 6.985, 6.978 (8H, aromatic H), 6.971 - 6.964, 6.957 - 6.950 (m, d, d, s, H of F) and 1.903 (s, 3H, CH<sub>3</sub>).<sup>13</sup>C-NMR (DMSO-d<sub>6</sub>): 195.63, 164.73, 163.06, 161.66, 153.43, 140.91, 131.69, 131.11, 131.09 - 129.99, 115.21, 115.06, 114.95, 77.88 - 77.44, 40.02, and 39.19. Analy. Calcd: C, 57.86; H, 3.04; N, 12.13; and F, 9.64%, for C<sub>19</sub>H<sub>12</sub>N<sub>6</sub> F<sub>2</sub>O<sub>2</sub> (394). Found: C, 57.49; H, 2.89; N, 21.01; and F, 9.33%.</p>
<p class="E-Title3">2.1.14. 5,6-Di(4׳-fluorophenyl)-3-(3׳-mercapto-1,2,4-triazol-4׳-yl)-1,2,4-triazine (15)</p>
<p>A mixture of 11 (0.01 mol) and triethyl orthoformate (0.01 mol) was refluxed for 2 h and then cooled at room temperature. The solid obtained was filtered and crystallized from dioxan to give 15 as yellow crystals, yield 72%, m.p. 183˚C - 184˚C. IR (n/cm-<sup>1</sup>): 3298, 3191 (NH), 1610, 1576 (C=N), 1381 (NCN), 1225 (C-F), 1157 (C=S), 840 and 810 (p-substituted ring).<sup> 1</sup>H-NMR (DMSO-d<sub>6</sub>): 10.03 (S, 1H, NH=S), 7.60 - 511, 7.48 - 7.27 and 7.0 - 6.55 (m, 9H, aromatic H). Analy. Calcd: C, 55.43; H, 2.71; N, 22.82; F.10.32 and S, 8.69%, for C<sub>17</sub>H<sub>10</sub>N<sub>6</sub>F<sub>2</sub>S (368). Found: C, 55.21; H, 2.33; N, 22.55; F.10.01 and S, 8.49%.</p>
<p class="E-Title3">2.1.15. 5,6-Di(4׳-fluorophenyl)-3-(3׳,5׳-dimercapto-1׳,2׳,4׳-triazol-4׳-yl)-1,2,4-triazine (16)</p>
<p>A mixture of 11 (0.01 mol) and carbon disulfide (0.01 mol) in DMF was refluxed for 2 h and then cooled at room temperature. The solid obtained was filtered and crystallized from methanol to give 16 as orange crystals, yield 80%, m.p. 203˚C - 204˚C. IR (n/cm<sup>−1</sup>): 3197 (NH), 3150 (NH), 1595 (C=N), 1564 (C=N), 1382 (NCN), 1224 (C-F), 1151(C=S), 831 and 810 (p-substituted ring).<sup> 13</sup>C-NMR (DMSO-d<sub>6</sub>): 163.99162.90، ، ،161.47 161.26 ، ،154.96 147 ، 132.25 ، 132.23 ، 131.89 ، 131.87 131.31 130.56 ، ، 130.50 ، 115.02 ، 114.88 ، 77 and 77.69-78.12. Analy. Calcd: C, 51.0; H, 2.50; N, 21.0; F, 9.5; and S, 16.0%, for C<sub>17</sub>H<sub>10</sub>N<sub>6</sub>F<sub>2</sub>S<sub>2</sub> (400). Found: C, 50.85; H, 2.31; N, 20.88; F, 9.33; and S.15.79%.</p>
<p class="E-Title3">2.1.16. 5,6-Diaryl-3-(6׳-methyl-3׳-mercapto-6׳-oxo-1׳,2׳,4׳-triazin-4׳-yl)-1,2,4-triazine (17)</p>
<p>A mixture of 11 (0.01 mol) and sodium pyruvate (0.01 mol) in 5% NaOH aq. (20 ml) was refluxed for 3h. The reaction mixture was cooled and then poured on ice cold HCl solution. The solid obtained was filtered and crystallized from ethanol to give 17 as yellow crystals, yield 60%, m.p. 220-222˚C. IR (n/cm<sup>−1</sup>): 3197 (NH), 2906, 2855(CH<sub>3</sub>), 1666 (C=C), 1586 (C=N), 1472 (deformation CH<sub>3</sub>), 1367 (NCN), 1224 (C-F), 1158 (C=S), 872 and 792 (p-substituted ring). <sup>1</sup>H-NMR (DMSO-d<sub>6</sub>): 11.86 (S, 1H, NH), 7.75 - 7.38, 7.30 - 7.28 (each, m, 8H, aromatic H), 6.97 - 6.69 (d, d, s, H-CF), and 1.08 (S, 3H, CH<sub>3</sub>). <sup>13</sup>C-NMR (DMSO-d<sub>6</sub>): 180, 163.98, 162.91, 161.27, 154.96, 147.84, 132.21, 131.85, 131.36, 131.30, 130.55 - 130.02, 115.02, 114.88, 78.03 - 77.60 and 39.20. Analy. Calcd: C, 55.60; H, 2.92; N, 20.48; F, 9.26; and S.7.80%, for C<sub>19</sub>H<sub>12</sub>N<sub>6</sub>F<sub>2</sub>SO (410). Found: C, 55.39; H, 2.80; N, 20.29; F.9.01 and S, 7.55%.</p>
<p class="E-Title3">2.1.17. N,N׳-[5,6-di(4&cent;fluorophenyl)-1,2,4-triazin-3&cent;-yl]thiourea (18)</p>
<p>Equimolar amount of compounds 1 and 9 in ethanol (50 ml) was refluxed for 2 h. The reaction mixture was cooled in an ice bath to form a solid which was filtered and crystallized from ethanol to give 18 as faint yellow crystals, yield 65%, m.p. 193˚C - 194˚C. IR (n, cm<sup>−1</sup>): 3300, 3289, 3192 (C-F), 1157(C=S), 827 and 814 (p- substituted ring). Analy. Calcd: C, 60.98; H, 2.95; N, 18.36; F, 12.45; and S.5.24%, for C<sub>31</sub>H<sub>18</sub>N<sub>8</sub>F<sub>4</sub>S (610). Found: C, 60.65; N, 2.80; F, 12.13; and S, 5.00%.</p>
<p class="E-Title3">2.1.18. N,N׳-Di[di(4׳-fluorophenyl)1,2,4-triazin-3-yl]-thiobarbituric Acid (19)</p>
<p>A mixture of 18 (0.01 mol) and malonic acid (0.01 mol) in glacial acetic acid (50 ml) was refluxed for 4h. The reaction mixture was cooled and then poured onto ice. The solid obtained was filtered and crystallized from ethanol to give 19 as yellow crystals, yield 60%, m.p. 300˚C - 302˚C. UV (Ethanol): λ<sub>max</sub> 334 nm. IR (n/cm<sup>−1</sup>): 2980, 2868 (aliphatic CH), 1663 (C=O), 1595, 1561(C=N), 1366 (NCN), 1223 (C-F), 1156 (C=S), 854 and 820 (p-substituted ring). <sup>1</sup>H-NMR (DMSO-d<sub>6</sub>): 13.52 (s. IH, OH), 7.82 - 7.00 (m, 16H, aromatic H), 6.98, 6.97, 6.85(d, d, S, H, of C-F) and 2.499 (S, CH<sub>2</sub>). <sup>13</sup>C-NMR (DMSO-d<sub>6</sub>):180, 165.68, 164.65, 163.27, 162.98, 161.62, 154.93, 140.95, 131.95 - 130.14, 115.22, 114.89, 78.28 - 77.85 and 24.88. Analy. Calcd: C, 60.15; H, 2.66; N, 16.49; F, 11.10; and S, 4.55%. for C<sub>34</sub>H<sub>18</sub>N<sub>8</sub>F<sub>4</sub>SO<sub>2 </sub>(678). Found: C, 59.89; H, 2.51; N, 16.30; F, 10.89; and S, 4.40%.</p>
<p class="E-Title3">2.1.19. N,N׳-Di[di(4׳-fluorophenyl)1,2,4-triazin-3-yl]-5-arylidene-thiobarbituric Acid (20)</p>
<p>Equimolar quantity of 19 and 4-chlorobenzaldehyde in ethanol (50 ml), piperidine (0.5 ml) was refluxed for 6h. The reaction mixture was cooled and neutralized with few drops of acetic acid. The solid precipitated was filtered and crystallized from ethanol to give 20 as yellow crystals, yield 60%, m.p. 310˚C - 312˚C. UV (EtOH): λ<sub>max</sub> 346 nm. IR (n, cm<sup>−1</sup>): 3080 (aromatic CH), 2920, (aliphatic CH), 1710, 1680(2C=O), 1385 (NCSN), 1250 (C-F), 1190 (C-S), 880 and 810 (p-substituted ring). <sup>1</sup>H-NMR (DMSO-d<sub>6</sub>): 7.66 - 7.64, 7.38 - 7.36, 7.29 - 7.27, (each, m, 21H, aromatic H), 6.61, 6.96 and 6.92, (CH=, d, d, s, of H adjacent to the F atoms). <sup>13</sup>C-NMR (DMSO-d6): 180, 164, 162.94, 162.36, 161.30, 155.02, 147.89, 132.14, 131.79, 131.34, 131.28, 130.53, 130.48, 115.03, 114.88, 77.90 - 77.47, 66.42 and 40.12 - 39.17. Analy. Calcd: C, 61.42; H, 2.62; N, 13.48; F, 9.48, Cl, 4.49; and S, 3.99%, for C<sub>41</sub>H<sub>21</sub>N<sub>8</sub>FClSO<sub>2 </sub>(801). Found: C, 61.01; H, 2.55; N, 12.98; F, 9.03; Cl. 3.99 and S, 3.55%.</p>
<p class="E-Title1">3. Results and Discussion</p>
<p class="E-Title2">3.1. Chemistry</p>
<p>3-Amino-1,2,4-triazines are important intermediates in the synthesis of heterobicylic systems. Also, 5,6-di- phenyl-1,2,4-triazine containing functional groups at position-3, especially amino and/or hydrazine groups, are used as nucleophilic reagents (electron donors) towards π-acceptors carbonitriles [25] . In addition, in most of these reactions, DMF is used as a strong polar aprotic solvent which accelerates the SN<sup>2</sup> reactions [26] .</p>
<p>Nucleophilic attack on exo C=N bonds of 1,2,4-trizaine provides a direct and convenient method for functionalization of 1,2,4-triazines, which makes it possible to introduce various substituents in a single reaction. Thus, it is quite probable that their reactions with bifunctional nucleophiles would result in polycyclic compounds via attack by the second nucleophilic center at another carbon atom of hetero-ring [26] .</p>
<p>The presence of hetero atoms results in significant changes in the cyclic molecular structure, due to the availability of unshared pairs of electrons on nitrogen atoms and the difference in electronegativity between heteroatoms and carbons within the closed system.</p>
<p>The starting material 3-amino5,6-di(4׳-fluorophenyl)-1,2,4-triazine (1) was prepared from refluxing amino-guanidine bicarbonate with 4,4׳-difluorobenzil in n-ButOH [27] (Scheme 1). Structure of compound 1 was deduced from elemental analysis and spectral data. IR spectrum showed an absorption bands at 3200, 1620 cm<sup>−1</sup> for NH<sub>2</sub> group, and 1250 cm<sup>−1 </sup>for C-F. <sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) recorded δ at 2.89-1 (br, s, 2H, NH<sub>2</sub>), 7.31 - 7.34, 7.39 - 7.44 ppm for 8 aromatic protons with δ at 7.0-6.61 ppm as a characteristic doublet and a signal for the adjacent H to the F atom. <sup>13</sup>C-NMR spectrum exhibited a resonance signals for carbons at δ 127.7 - 129.8 for aromatic carbons and four other peaks at δ 136, 148, 156, and 161 ppm for C=N, C-N, C-F and C-NH<sub>2</sub> respectively.</p>
<p>X-ray analysis of 1,2,4-triazine ring reveal that the ring is slightly distorted due to the asymmetry induced by the electronegativity of nitrogen atoms and two intermolecular hydrogen bonds that stabilized the 1,2,4-triazine structure [28] .</p>
<p><img src="//html.scirp.org/file/6-1020411x6.png" class="100" /></p>
<p>Scheme 1. Synthesis of 2 and 3.</p>
<p>The ring closure of 3-amino-5,6-di(4׳-fluorophenyl)-1,2,4-triazine (1) with chloroacetonitrile in boiling DMF produced 3-amino-6,7-di(4׳-fluorophenyl)imidazolo[3,2-b][1,2,4]triazine (2), while reaction of 1 with monochloro acetic acid in refluxing DMF yielded 2,3-dihydro-6,7-diaryl-imidazolo[3,2-b][1,2,4]triazin-3-one (3). Moreover, compound 3 was also obtained via basic hydrolysis of 2 by warming in aqueous NaOH.</p>
<p>Structure of compound 2 showed a characteristic bands at 3350 and 1623 cm<sup>−1</sup> attributed to NH<sub>2</sub> group while that of compound 4 had a characteristic band at 1660 cm<sup>−1</sup> for C=O, in addition to bands at 2950 and 1480 cm<sup>−1 </sup>for CH<sub>2</sub> group and an additional absorption at 1226 cm<sup>−1</sup> for C-F. Mass spectra of 3 showed a molecular ion peak at m/z 323, with a base peak at m/z 214 for 4,4׳-difluorophenyl acetylene radical [29] .</p>
<p>Ring closure reactions of compound 1 with diethyl malonate and/or ethyl cyanoacetate in refluxing THF afforded 1,2,3,4-tetrahydro-7,8-di(4′-fluorophenyl)-pyrimido[3,2-b][1,2,4]traizin-2,4-dione (4) and 4-amino-7, 8-di(4′-fluorophenyl)-pyrimido[3,2-b][1,2,4]traizin-2-one (6), respectively. The condensation of both 4 and 6 with aromatic aldehyde in boiling ethanol?piperidine gave the arylidene 5 and the Schiff base 7 (Scheme 2).</p>
<p>Structures of both compounds 4 and 6 were elucidated from their analytical and spectral data. IR spectrum of 4 showed absorption bands at 1680 and 1650 cm<sup>−1</sup> for the two C=O groups, while that of 6 recorded absorption bands at 3300, 1670 cm<sup>−1</sup> due to NH<sub>2</sub> and C=O groups, respectively. Mass spectrum of 6 recorded a molecular ion peak at 351 m/z and a base peak at 214 m/z. UV absorption spectrum of 5 showed a higher maximum (λ<sub>max</sub> = 351 nm) than that of 4 (λ<sub>max</sub> = 346 nm), due to the extended conjugation in the heterocyclic ring in the former. <sup>1</sup>H-NMR of 5 showed a prominent peak at δ 8.2 ppm due to C=CHAr. <sup>13</sup>C-NMR of compound 7 showed the resonance signal of exo N=CH in addition to an endo N=C of 1,2,4-triazine.</p>
<p>The treatment of compound 1 with ethyl chloroformate in benzene and triethylamine and/or CS<sub>2</sub>/KOH led to the formation of ethyl carboxylate 8 and the intermediate 9, respectively. Hydrazinolysis of 8 and 9 by refluxing with hydrazine hydrate in ethanol afforded N<sup>4</sup>-substituted semicarbazide/thiosemicarbazide 10 and 11, respectively (Scheme 3). IR spectra of both compounds 10 and 11 showed C=O and C=S at 3400, 3100 cm<sup>−1</sup> for NH, NH<sub>2</sub> groups, respectively.</p>
<p>Ring closure reactions of compound 10 with triethylorthoformate, carbondisulfide, dimethylformamide and/or sodium pyruvate (NaOH solution) led to the direct formation of 3-(2′,3′- dihydro-3′-oxo-1,2,4-triazol-4′- yl)-5,6- di(4′-fluorophenyl)-1,2,4-triazine(12), 3-(3′-oxo-1,2,3,4-tetrahydro-5′-thioxo-1,2,4-triazol-4′-yl)-5,6-di-(4′-flu- orophenyl)-1,2,4-triazine (13) and 3-(3′,4′-dihydro-3′,5′-dioxo-6′-methyl-1′,2′,4′-triazin-3′-yl)-5,6-di (4′-fluoro- phenyl)-1,2,4-triazine (14) (Scheme 4).</p>
<p>IR spectra of 12 and 14 evealed absorption bands at 3150 - 3100 and 1680 - 1660 cm<sup>−1</sup> for NH and C=O groups, respectively. <sup>1</sup>H-NMR spectrum of 14 showed resonance signals at δ 1.95, 13.48 and 8-6.6 ppm for CH<sub>3</sub>, NH and aromatic protons respectively. However compound 13 recorded a resonance C=S at δ 195 ppm. Mass spectra of 13 exhibit a molecular ion peak at m/z 384 and a base peak at m/z 214 due to 4,4'-difluorophenyl acetylene radical [29] .</p>
<p>Under the same experimental conditions, ring closure reactions of compound 11 with triethylorthoformate, carbondisulfide and sodium pyruvate resulted in 3-(2′,3′- dihydro-3′-thioxo-1′,2′,4′-triazol-4′-yl)-5,6-di(4′-fluo-</p>
<p><img src="//html.scirp.org/file/6-1020411x7.png" class="100" /></p>
<p>Scheme 2. Synthesis of 5 and 7.</p>
<p><img src="//html.scirp.org/file/6-1020411x8.png" class="100" /></p>
<p>Scheme 3. Synthesis of 10 and 11.</p>
<p><img src="//html.scirp.org/file/6-1020411x9.png" class="100" /></p>
<p>Scheme 4. Synthesis of 12-14.</p>
<p>rophenyl)-1,2,4-triazine (15), 3-(1′,2′,3′,4′-tetrahydro-3′,5′-thioxo-1′,2′,4′-triazol-4′-yl)-5,6-di(4′-fluorophenyl)- 1,2,4-triazine (16) and 3-(3′,4′-dihydro-3′-thioxo-6-methyl-5′-oxo-1,2,4-triazol-4′-yl)-5,6-di(4′-fluorophenyl)- 1,2,4-triazine (17), respectively (Scheme 5). IR spectra of compounds 15-17 showed an absorption bands at 3200-3100 and 1180-1150 cm<sup>−1</sup> for NH and C=S groups, respectively. <sup>1</sup>H-NMR of 17 recorded resonance signals at 1.08 and 11.85 ppm for CH<sub>3</sub> and NH protons, respectively. Also, <sup>13</sup>C-NMR exhibited resonances for C=S, C=O, C=N and CH<sub>3</sub> at δ 180, 163 and 130 ppm respectively.</p>
<p>Fluorinated N,N-disubstituted-thiobarbituric acid 19 was prepared from refluxing compound 9 with 1 in ethanol to give N,N-disubstituted-thiourea 18. Ring closure reaction of 18 with malonic acid on warming with glacial acetic acid yielded compound 19 (Scheme 6). IR spectra of compound 18 showed absorption bands at 3300 - 3190 cm<sup>−1</sup> for NH, NH of thiourea derivative which was not found in compounds 19 and 20. <sup>1</sup>H-NMR spectrum of compound 19 recorded a resonance signal at δ 2.44 ppm for CH<sub>2</sub> protons. Also, <sup>13</sup>C-NMR showed a signal at δ 24.88 ppm for aliphatic carbons. IR spectrum of 20 showed absorption bands at 1680, 1660 and 1611 cm<sup>−1</sup> for the two C=O and CH=C groups, in addition to two bands at 1255 and 1185 cm<sup>−1</sup> for C-F and C=S groups, respectively. <sup>13</sup>C-NMR of 20 exhibited resonance signals at δ 188, 166 and 39.48 ppm attributed to C=S, C=O and CH=C carbons, respectively. It is interesting to note that UV absorption of compound 20 recorded λ<sub>max</sub> at 334 nm which is higher than the value for compound 19 (λ<sub>max</sub> = 332), confirming ta presence of an α, β-unsaturated cyclic ketone system in the former.</p>
<p class="E-Title2">3.2. Biological Evaluation</p>
<p>The CDK2 inhibitory activity of the synthesized compounds revealed that eleven out of the tested twenty compounds displayed variable inhibitory effects. However compounds 11, 13, 16 and 17 showed profound activity.</p>
<p><img src="//html.scirp.org/file/6-1020411x10.png" class="100" /></p>
<p>Scheme 5. Synthesis of 15 and 17.</p>
<p><img src="//html.scirp.org/file/6-1020411x11.png" class="100" /></p>
<p>Scheme 6. Synthesis of 18-20.</p>
<p>Compound 16 was found to be equipotent to the positive reference Olomoucine.</p>
<p>Further examination of the structures of the active compounds revealed that all of them have almost similar N-(amino(hydrazinyl)methyl)hydrazinecarbothioamide scaffolding as displayed in <a href="#f1" target="_self">Figure 1</a> by bold bonds. Though these structural features are present in other active compounds but other molecular framework variants rends them less active and less sensitive towards the CDK2 enzyme. Also, the presence of mercapto-groups in fluorinated heterobicyclic nitrogen systems (11, 13, 16, 17) exhibited good effects toward cell damage (<a href="#t1" target="_self">Table 1</a>).</p>
<p>However, in vitro anti-tumor testing of the highly active compounds (11, 13, 16, 17) were evaluated according to the described method, under different concentrations, a sulforhodamine B (SRB) protein assay was used to estimate cell viability or growth by determining GI<sub>50</sub>, TGI and LC<sub>50</sub> (<a href="#t2" target="_self">Table 2</a>).</p>
<p>The results obtained, indicated that all the tested compounds were effective towards some types of tumors. Compound 11 was active against non-small cell lung cancer, renal cancer and breast cancer cell lines, while compound 13 had activity towards leukemia, renal cancer, non-small cell lung cancer and breast cancer. Furthermore, compounds 16 and 17 exhibited significant degrees of activity towards non-small cell lung cancer and breast cancer (<a href="#t2" target="_self">Table 2</a>).</p>
<div class="Css_sac">
 <p class="imgGroupCss_v"><img class=" imgMarkCss lazy" data-original="//html.scirp.org/file/6-1020411x12.png" /></p>
 <p class=" sacImgMarkCss"><a name="f1" id="f1"><span class="cs_fig_con">Figure 1</span></a>. Common structural features of the active compounds.</p>
</div> 
<div class="Css_sac">
 <p class="imgGroupCss_v"> <a href="//html.scirp.org/file/_6-1020411_1.htm" target="_blank"><img class="lazy" data-original="Images/Table_Tmp.jpg" /></a></p> 
 <p class="sacImgMarkCss"><a name="t1" id="t1"><span class="cs_fig_con">Table 1</span></a>. The CDK2 inhibitory activity of tested compounds (IC<sub>50</sub> in &micro;g/ml).</p>
</div>
<p>The data represent means values from three independent experiments plus the standard deviation (SD).</p> 
<div class="Css_sac">
 <p class="imgGroupCss_v"> <a href="//html.scirp.org/file/_6-1020411_2.htm" target="_blank"><img class="lazy" data-original="Images/Table_Tmp.jpg" /></a></p> 
 <p class="sacImgMarkCss"><a name="t2" id="t2"><span class="cs_fig_con">Table 2</span></a>. In vitro antitumor activity data of some active compounds.</p>
</div>
<p>GI<sub>50</sub>: concentration giving 50% inhibition; TGI: concentration giving total growth inhibition; LC<sub>50</sub>: concentration having 50% lethal effect; Δ is considered low if 1, moderate if &gt; 1 and high if ≥ 3; Subpanels showing a statistical measure of differential sensitivity with respect to the indicated response parameters.</p>
<p class="E-Title1">4. Conclusion</p>
<p>The synthesized α, β-bifunctional oxygen, sulfur, halogen and nitrogen derivatives of 1,2,4-triazines have shown promising CDK2 activities. Out of eleven active compounds, four of them (11, 13, 16 and 17) have shown very good CDK2 enzyme inhibiting activity. In these compounds N-(amino(hydrazinyl)methyl)hydrazinecarbo- thioamide scaffold was found to be an essential molecular feature in CDK2 enzyme inhibition activity. However these four compounds have also shown significant activity against various tumor cell-lines in subpanel assay.</p>
<p class="E-Title1">Acknowledgements</p>
<p>The authors are grateful to King Abdulaziz University for providing research facilities to perform the present research work.</p>
<p class="E-Title1">NOTES</p>
<p><sup>*</sup>Corresponding author.</p>
            </div>

        
         

            <div style="margin-top: 10px;">
                <p style="font-size: 16px; font-weight: bold;">Conflicts of Interest</p>
                <p style="text-align: justify;">The authors declare no conflicts of interest.</p>
            </div>
     

            <div style="margin-top: 10px;">
                <p style="font-size: 16px; font-weight: bold;">
                    <a name="reference" style="color: #2f2f2f;">References</a>
                </p>
                <p>
                    <table width="100%" border="0" cellspacing="0" cellpadding="0" style="text-align: left; word-break: break-word; ">
                        
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576359' target='_blank'>1</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref1" id="ref1"></a>
                                        Fuchs, T., Chowdhury, G., Barnes, C.L. and Gates, K.S. (2001) 3-Amino-1,2,4-benzotriazine 4-Oxide: Characterization of a New Metabolite Arising from Bioreductive Processing of the Antitumor Agent 3-Amino-1,2,4-benzotriazine 1,4-Dioxide (Tirapazamine). The Journal of Organic Chemistry, 66, 107-114. <br/>http://dx.doi.org/10.1021/jo001232j
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576360' target='_blank'>2</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref2" id="ref2"></a>
                                        Leach, M., Marden, C. and Miller, A. (1986) Pharmacological Studies on Lamotrigine, a Novel Potential Anti-Epileptic Drug: II Neuro-chemical Studies on the Mechanism of Action. Epilepsia, 27, 490-497. <br/>http://dx.doi.org/10.1111/j.1528-1157.1986.tb03573.x
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576361' target='_blank'>3</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref3" id="ref3"></a>
                                        Ibrahim, M.A., Abdel-Rahman, R.M., Abdel-Halim, A.M., Ibrahim, S.S. and Allimony, H.A. (2008) Synthesis and Antifungal Activity of Novel Polyheterocyclic Compounds Containing 1,2,4-Triazine Moiety. Arkivoc, Xvi, 202-215.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576362' target='_blank'>4</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref4" id="ref4"></a>
                                        Abdel-Rahman, R.M., Makki, M.S.T., Ali, T.E. and Ibrahim, M.A. (2012) 1,2,4-Triazine Chemistry Part III: Synthetic Strategies to Functionalized Bridgehead Nitrogen Heteroannulated 1,2,4-Triazine Systems and Their Regiospecific and Pharmacological Properties, Current Org. Synthesis, 9, 1-25. The Merck Index & Co. Inc., White house Station, NJ, USA, (2006) 1953.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576363' target='_blank'>5</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref5" id="ref5"></a>
                                        Abdel-Rahman, R.M. (2001) Rrole of Uncondensed 1,2,4-Triazine Compounds and Related Heterocyclic Systems as Therapeutic Agents. Pharmazie, 56, 18-30.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576364' target='_blank'>6</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref6" id="ref6"></a>
                                        Abdel-Rahman, R.M. (1991) Synthesis and Anti Human Immune Virus Activity of Some New Fluorine Containing Substituted 3-Thioxo-1,2,4-triazin-5-ones, Farmaco, 46, 379-389.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576365' target='_blank'>7</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref7" id="ref7"></a>
                                        Mamolo, M.G., Falagiani, V., Zampieri, D., Vio, L. and Banfi, E. (2000) Synthesis and Antimycobacterial Activity of Some 4H-1,2,4-Triazin-5-one Derivatives. Il Farmaco, 55, 590-595. <br/>http://dx.doi.org/10.1016/S0014-827X(00)00074-4
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576366' target='_blank'>8</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref8" id="ref8"></a>
                                        Abdel-Rahman, R.M., Morsy, J.M., Hanafy, F.I. and Amine, H.A. (1999) Synthesis of Heterobicyclic Nitrogen Systems Bearing the 1,2,4-Triazine Moiety as Anti-HIV and Anticancer Drugs; Part I. Pharmazie, 54, 347-351.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576367' target='_blank'>9</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref9" id="ref9"></a>
                                        Liu, K.C.H., Shih, Bi-J. and Lee, Ch-Hs (1993) Synthesis of Representative 10-aryl-, 10-Aralkyl- and 10-Heteroaryl-9H-naphtha[1′,2′:4,5]thiazolo[3,2-b][1,2,4]triazin-9-ones as Potential Anti HIV Agents. Journal of Heterocyclic Chemistry, 10, 1331-1335. <br/>http://dx.doi.org/10.1002/jhet.5570300525
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576368' target='_blank'>10</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref10" id="ref10"></a>
                                        Russell, M.G., Carling, R.W., Street, L.J., Hallett, D.J., Goodacre, S., Mezzogori, E., Reader, M., Cook, S.M., Bromidge, F.A., Newman, R., Smith, A.J., Wafford, K.A., Marshall, G.R., Reynolds, D.S., Dias, R., Ferris, P., Stanley, J., Lincoln, R., Tye, S.J., Sheppard, W.F., Sohal, B., Pike, A., Dominguez, M., Atack, J.R. and Castro, J.L. (2006) Discovery of Imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 Subtype Selective Agonists for the Treatment of Anxiety. Journal of Medical Chemistry, 49, 1235-1238. <br/>http://dx.doi.org/10.1021/jm051200u
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576369' target='_blank'>11</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref11" id="ref11"></a>
                                        Koek, W., Patoiseau, J.F., Assie, M.B., Cosi, C. and Kleven, M.S. Dupont-Passelaigue, E., Carilla-Durand, E., Palmier, C., Valentin, J.P., John, G., Pauwels, P. J., Tarayre, J.-P. and Colpaert, F.C. (1998) F 11440, a Potent, Selective, High Efficacy 5-HT1A Receptor Agonist with Marked Anxiolytic and Anti-Depressant Potential. Journal of Pharmacology and Experimental Therapeutics, 287, 266-283.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576370' target='_blank'>12</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref12" id="ref12"></a>
                                        El-Gendy, Z., Morsy, J., Allimony, H.A., Abdel-Monem, W. R. and Abdel-Rahman R. M. (2001) Synthesis of Heterobicyclic Nitrogen Systems Bearing the 1,2,4-Triazine Moiety as anti HIV and Anticancer Drugs, Part III. Pharmazie, 56, 376-382.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576371' target='_blank'>13</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref13" id="ref13"></a>
                                        El-Gendy, Z., Morsy, J.M., Allimony, H.A., Abdel-Monem, W.R. and Abdel-Rahman R.M. (2003) Synthesis of heterobicyclic nitrogen systems bearing a 1,2,4-triazine moiety as anticancer drugs, Part IV. Phosphorus, Sulfur, and Silicon and the Related Elements, 178, 2055-2071. <br/>http://dx.doi.org/10.1080/10426500390228738
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576372' target='_blank'>14</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref14" id="ref14"></a>
                                        Abdel-Rahman, R.M., Morsy, J., El-Edfawy, S. and Amine, H.A. (1999) Synthesis of Some Heterobicyclic Nitrogen Systems Bearing the 1,2,4-Triazine Moiety as Anti HIV and Anticancer Drugs, Part II. Pharmazie, 54, 667-671.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576373' target='_blank'>15</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref15" id="ref15"></a>
                                        Mohared, R.M., Ibrahim, R.A. and Moustafa, H.E. (2010) Hydrazide-Hydrazones in the Synthesis of 1,3,4-Oxadiazine, 1,2,4-Triazine and Pyrazole Derivatives with Antitumor Activities. The Open Organic Chemistry Journal, 4, 8-14.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576374' target='_blank'>16</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref16" id="ref16"></a>
                                        El-Nagger, S.A., El-Barbary, A.A., Mansour, M.A., Abdel-Shafy, F. and Talat S. (2011) Anti-Tumor Activity of Some 1,3,4-Thiadiazoles and 1,2,4-Triazine Derivatives against Ehrlichs Ascites Carcinoma. International Journal of Cancer Research, 7, 278-288. <br/>http://dx.doi.org/10.3923/ijcr.2011.278.288
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576375' target='_blank'>17</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref17" id="ref17"></a>
                                        Smart, B.E. (2001) Fluorine Substituent Effects (on Bioactivity). Journal of Fluorine Chemistry, 109, 3-11. <br/>http://dx.doi.org/10.1016/S0022-1139(01)00375-X
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576376' target='_blank'>18</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref18" id="ref18"></a>
                                        Ismail, F.M.D. (2002) Important Fluorinated Drugs in Experimental and Clinical Use. Journal of Fluorine Chemistry, 118, 27-33. <br/>http://dx.doi.org/10.1016/S0022-1139(02)00201-4
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576377' target='_blank'>19</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref19" id="ref19"></a>
                                        Dolbier Jr., W.R. (2005) Fluorine Chemistry at the Millennium. Journal of Fluorine Chemistry, 126, 157-163. <br/>http://dx.doi.org/10.1016/j.jfluchem.2004.09.033
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576378' target='_blank'>20</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref20" id="ref20"></a>
                                        Isanbor, C. and O’Hagan, D. (2006) Fluorine in Medicinal Chemistry: A Review of Anti-Cancer Agents. Journal of Fluorine Chemistry, 127, 303-319. <br/>http://dx.doi.org/10.1016/j.jfluchem.2006.01.011
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576379' target='_blank'>21</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref21" id="ref21"></a>
                                        Abdel-Rahman, R.M. (2001) Synthesis and Chemistry of Fluorine Containing 1,2,4-Triazine. Pharmazie, 56, 791-804.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576380' target='_blank'>22</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref22" id="ref22"></a>
                                        Workman, P. (2005) Genomics and the Second Golden Era of Cancer Drug Development. Molecular BioSystems, 1, 17-26. <br/>http://dx.doi.org/10.1039/b501751n
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576381' target='_blank'>23</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref23" id="ref23"></a>
                                        Morgan, D.O. (1997) Cyclin-Dependent Kinases: Engines, Clocks, and Microprocessors. Annual Review of Cell and Developmental Biology, 13, 261-291. <br/>http://dx.doi.org/10.1146/annurev.cellbio.13.1.261
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576382' target='_blank'>24</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref24" id="ref24"></a>
                                        Satyanarayana, A. and Kaldis, P. (2009) A Dual Role of Cdk2 in DNA Damage Response. Cell Division, 4, 9. <br/>http://dx.doi.org/10.1186/1747-1028-4-9
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576383' target='_blank'>25</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref25" id="ref25"></a>
                                        Abdel-Rahman, R.M. (1999) Chemistry of Uncondensed 1,2,4-Triazines Part I, Chemical Reactivity of 5,6-Diphenyl- 1,2,4-triazine-5-yl Containing Active Groups. Trends in Heterocyclic Chemistry, 6, 126-133.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576384' target='_blank'>26</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref26" id="ref26"></a>
                                        Abdel-Rahman, R.M. (2001) Chemistry of Uncondensed 1,2,4-Triazines Part IV. Synthesis and Chemistry of Bioactive 3-Amino-1,2,4-triazines and Related Compounds. Pharmaize, 56, 275-286.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576385' target='_blank'>27</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref27" id="ref27"></a>
                                        Musator, D.M., Kurilor, D.V. and Rakisher, A.K. (2008) Efficient Synthesis of 3-Amino-5,6-diphenyl-1,2,4-triazine. Ukrainica Bioorganica Act, 1, 61-62.
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576386' target='_blank'>28</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref28" id="ref28"></a>
                                        Hwang, L.-C., Wu, R.-R., Jane, S.-Y. and Lee, G.-H. (2003) Crystals Structure of 3-Amino-1,2,4-triazine. Analytical Sciences, 19, x73-x74. <br/>http://dx.doi.org/10.2116/analscix.19.x73
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td width="45" valign="top">
                                        [<a href='../reference/referencespapers?referenceid=1576387' target='_blank'>29</a>]
                                    </td>
                                    <td valign="top" style="word-wrap:break-word; ">
                                        <a target="_self" name="ref29" id="ref29"></a>
                                        Palmer, M.H., Preston, P.N. and Steven, M.F.G. (1971) The Mass Spectra of 1,2,4-Triazines and Related Compounds. Organic Mass Spectrometry, 5, 1085-1092. <br/>http://dx.doi.org/10.1002/oms.1210050908
                                    </td>
                                </tr>
                            
                    </table>
                </p>
            </div>

        </div>





    

    
    <link href="//www.scirp.org/css/html.css?timestamp=202411141045303414" rel="stylesheet" type="text/css" />
    
    <script type="text/javascript" src="//www.scirp.org/js/lazyload.js?timestamp=202411141045303414"></script>
    <script type="text/javascript" src="//www.scirp.org/js/ref.js?timestamp=202411141045303414"></script>
    


    <script type="text/javascript"  src="//www.scirp.org/js/htmlinsert.js?timestamp=202411141045303414"></script>
<script type="text/javascript" >

    window.onload = function () {
        var device = tools.currDevice()
        // ipad mobile 和 ipad true
        // iphone mobile 和 iphone true
        // android mobile 和 android true
        if (device.isMobile && (device.iphone || device.android)) {
            return false;
        }
        tools.replaceNode()
    }
</script>


<script src="//www.scirp.org/js/crossmark_widget.js" type="text/javascript"></script>

                    </div>
                </div>

                <div class="col-md-3 column col-md-pull-9">
                    <div class="row clearfix bg_w visible-md visible-lg">
                        <div class="title_up">Journals Menu</div>
                        <div class="column txt3">
                            

<ul class="list-unstyled">
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/journalarticles?journalid=527" target="_top">&nbsp;&nbsp;Articles</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/home?journalid=527" target="_top">&nbsp;&nbsp;Archive</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/indexing?journalid=527" target="_top">&nbsp;&nbsp;Indexing</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/aimscope?journalid=527" target="_top">&nbsp;&nbsp;Aims & Scope</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/editorialboard?journalid=527"  target="_top">&nbsp;&nbsp;Editorial Board</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/forauthors?journalid=527"  target="_top">&nbsp;&nbsp;For Authors</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/apc?journalid=527" target="_top">&nbsp;&nbsp;Publication Fees</a></li>
</ul>

                        </div>
                    </div>

                    <div class="row clearfix bg_w visible-xs visible-sm">
                        <div class="panel-group column" id="accordion" style="margin-bottom: 0;">
                            <div class="panel panel-default" style="border: none;">
                                <div class="panel-heading" style="background: #fff; padding: 0; margin: 0;">
                                    <h4 class="panel-title">
                                        <a class="link1" data-toggle="collapse" data-parent="#accordion" href="#collapse1">Journals Menu&nbsp;&nbsp;<i class="fa fa-angle-down"></i>
                                        </a>
                                    </h4>
                                </div>
                                <div id="collapse1" class="panel-collapse collapse">
                                    <div class="panel-body txt3" style="padding: 10px 0 0 0;">
                                        

<ul class="list-unstyled">
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/journalarticles?journalid=527" target="_top">&nbsp;&nbsp;Articles</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/home?journalid=527" target="_top">&nbsp;&nbsp;Archive</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/indexing?journalid=527" target="_top">&nbsp;&nbsp;Indexing</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/aimscope?journalid=527" target="_top">&nbsp;&nbsp;Aims & Scope</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/editorialboard?journalid=527"  target="_top">&nbsp;&nbsp;Editorial Board</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/forauthors?journalid=527"  target="_top">&nbsp;&nbsp;For Authors</a></li>
    <li><i class="fa fa-chevron-right" style="color: #d71318;"></i><a href="../journal/apc?journalid=527" target="_top">&nbsp;&nbsp;Publication Fees</a></li>
</ul>

                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>

                     
                    <div id="relatedArticles"></div>
                    <div id="div_sep" class="row clearfix bg_w">
                       

<div class="column left_link1">
    <ul class="list-unstyled">
        <li><a href="../journal/openspecialissues?journalid=527&PubState=false" target="_blank">
            Open Special Issues</a></li>
        <li><a href="../journal/openspecialissues?journalid=527&PubState=true" target="_blank">
            Published Special Issues</a></li>
        <li><a href="../journal/openspecialissuesguideline?journalid=527" target="_blank">
            Special Issues Guideline</a></li>
    </ul>
</div>

                    </div>
                    

<div class="row clearfix bg_w">
    <div class="column right_link1">
        <ul class="list-unstyled">
            <li><a href="../journal/newslettersubscription?journalid=527" target="_blank">
                E-Mail Alert</a></li>            
            <li><a href="../journal/subscribejournal?journalid=527" target="_blank">IJOC
                Subscription</a></li>
            <li><a href="../journal/publicat_ethics_statement?journalid=527" target="_blank">
                Publication Ethics & OA Statement</a></li>
            <li><a href="../journal/faq?journalid=527" target="_blank">
                Frequently Asked Questions</a></li>
            <li><a href="../journal/recommendtopeers?journalid=527" target="_blank">
                Recommend to Peers</a></li>
            <li><a href="../journal/recommendtolibrary?journalid=527" target="_blank">
                Recommend to Library</a></li>
            <li><a href="../journal/contactus?journalid=527" target="_blank">
                Contact us</a></li>
            <li id="UserControl_Reacommend_div_ojuDisclaimer" style="DisPlay:None;"><a href="../journal/disclaimer?journalid=527" target="_blank">
                Disclaimer</a></li>
            <li id="UserControl_Reacommend_div_historyIssue" style="DisPlay:None;"><a href="../journal/historyissue?journalid=527" target="_blank">
                History Issue</a></li>
        </ul>
    </div>
</div>


                    <div id="journalSponsors"></div>

                    
                    <div class="row clearfix bg_w">
                        



<div class="column">
    <div class="title_up">Follow SCIRP</div>
    <div style="padding-top: 10px;">
        <table width="100%" border="0" cellspacing="0" cellpadding="0">
            <tr>
                <td align="left"><a href="https://twitter.com/Scirp_Papers" class="tooltip-hide" data-toggle="tooltip" data-placement="left" title="Twitter" target="_blank">
                    <img src="../images/Twitter.svg" height="30" alt="Twitter"></a></td>
                <td align="left"><a href="https://www.facebook.com/Scientific-Research-Publishing-267429817016644/" class="tooltip-hide" data-toggle="tooltip" data-placement="left" title="Facebook" target="_blank">
                    <img src="../images/fb.svg" height="30" alt="Facebook"></a></td>
                <td align="left"><a href="https://www.linkedin.com/company/scientific-research-publishing/" class="tooltip-hide" data-toggle="tooltip" data-placement="left" title="Linkedin" target="_blank">
                    <img src="../images/in.svg" height="30" alt="Linkedin"></a></td>
                <td align="left"><a href="http://e.weibo.com/scirp" class="tooltip-hide" data-toggle="tooltip" data-placement="left" title="Weibo" target="_blank">
                    <img src="../images/weibo.svg" height="30" alt="Weibo"></a></td>
                
            </tr>
        </table>
    </div>
</div>


                    </div>
                    <div class="row clearfix bg_w">
                        



<div class="column">
    <div class="title_up">Contact us</div>
    <div style="padding-top: 5px;">
        <table width="100%" border="0" cellspacing="0" cellpadding="0">
             <tr>
                <td style="text-align:left; width:25px;" ><img border='0' src="../images/phone02.jpg"  style="float: left;" /></td>
                <td style="padding-left:5px;">+1 323-425-8868</td>           
            </tr>
            <tr>
                <td style="text-align:left; width:25px;" ><img border='0' src="../images/emailsrp.png"  style="float: left;" /></td>
                <td style="padding-left:5px;"><a href="mailto:customer@scirp.org" target="_blank">customer@scirp.org</a></td>           
            </tr>
            <tr>
                <td><img border='0' src="../images/whatsapplogo.jpg" alt='WhatsApp' title='WhatsApp' style="float: left;" /></td>
                <td style="padding-left:5px;">+86 18163351462(WhatsApp)</td>
            </tr>
            <tr>
                <td><a target='_blank' href='http://wpa.qq.com/msgrd?v=3&uin=1655362766&site=qq&menu=yes' rel="nofollow"><img border='0' src="../Images/qq25.jpg" alt='Click here to send a message to me' title='Click here to send a message to me' style="float: left;" /></a></td>
                <td style="padding-left:5px;"><a target='_blank' href='http://wpa.qq.com/msgrd?v=3&uin=1655362766&site=qq&menu=yes' rel="nofollow">1655362766</a></td>
            </tr>
            <tr>
                <td style="vertical-align:top;"><img border='0' src="../images/weixinlogo.jpg"  /></td>
                <td style="padding-left:5px;"><img border='0' src="../images/weixinsrp120.jpg"  /></td>
            </tr>
            <tr>
                <td></td>
                <td style="padding-left:5px;">Paper Publishing WeChat</td>
            </tr>
        </table>
    </div>
</div>







                    </div>
                </div>

            </div>

        </div>

        <div id="papercopyright">
            <div id="UserControl_PaperCopyRight_div_showby" class="clearfix text-center" style="border-top: #ccc 2px solid; background: #fff; padding: 10px; margin-top: 10px; font-size: 12px;">
    <p>Copyright &copy; 2025 by authors and Scientific Research Publishing Inc. </p>
    <p><a rel="license" href="http://creativecommons.org/licenses/by/4.0/"><img alt="Creative Commons License" title="Creative Commons License" style="border-width: 0" src="../Images/ccby.png" width="88" height="31" /></a></p>
    <p>This work and the related PDF file are licensed under a <a about="http://dx.doi.org/10.4236/ijoc.2015.53020" rel="license" href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</a>.</p>
</div>


        </div>
        <div id="footer">
            



<div style="border-top: #d71318 8px solid; padding: 20px 0; margin-top: 20px;">
    <div class="container row clearfix center-block" style="padding: 0;">
        

<script type="text/javascript">
    function checksubscribe() {
        
        var email = $("#UserControl_footer_UserControl_NewsletterSubscription_TextBox_nls_email").val();//Email   id=UserControl_NewsletterSubscription_TextBox_email       
        if (email == "" || email == "E-mail address") {
            alert('Please enter an email address!');
            return false;
        }
        var emailRegExp = new RegExp("[a-z0-9!#$%&'*+/=?^_`{|}~-]+(?:\.[a-z0-9!#$%&'*+/=?^_`{|}~-]+)*@(?:[a-z0-9](?:[a-z0-9-]*[a-z0-9])?\.)+[a-z0-9](?:[a-z0-9-]*[a-z0-9])?");
        if (!emailRegExp.test(email) || email.indexOf('.') == -1) {
            alert('The email address that you entered is invalid!');
            return false;
        }
        return true;
    }
</script>

<div class="col-sm-3 column" style="padding-right: 30px;">
    <span style="margin-bottom: 10px; font-size: 16px; line-height: 1.2em;"><strong>Free SCIRP Newsletters</strong></span>
    <div style="background: #dddddd; border-radius: 6px; box-shadow: 3px 3px 0px #9f9f9f; padding: 10px; margin-bottom: 10px;">

        <div role="form" class="form-inline">
            <div id="UserControl_footer_UserControl_NewsletterSubscription_panel_newsletter" onkeypress="javascript:return WebForm_FireDefaultButton(event, &#39;UserControl_footer_UserControl_NewsletterSubscription_btnSubscribe&#39;)">
	
                <div class="form-group" style="margin-bottom: 5px;">
                    <span for="name" style="font-size: 12px; line-height: 1.5em; font-weight: bold;">Add your e-mail address to receive free newsletters from SCIRP.</span>

                    <input name="ctl00$UserControl_footer$UserControl_NewsletterSubscription$TextBox_nls_email" type="text" value="E-mail address" id="UserControl_footer_UserControl_NewsletterSubscription_TextBox_nls_email" class="form-control" onFocus="javascript:if(this.value==&#39;E-mail address&#39;) {this.value=&#39;&#39;;}" onBlur="javascript:if(this.value==&#39;&#39;){this.value=&#39;E-mail address&#39;;}" style="width: 100%; background: #fff; border: #2f2f2f 1px solid; border-radius: 0; height: 25px;" />
                </div>

                <div class="form-group" style="margin-bottom: 5px; width: 100%;">

                    <select name="ctl00$UserControl_footer$UserControl_NewsletterSubscription$DropDownList_journal" id="UserControl_footer_UserControl_NewsletterSubscription_DropDownList_journal" class="form-control" style="width: 100%; height: 25px; border: #2f2f2f 1px solid; border-radius: 0; padding: 0 8px; color: #999;">
		<option value="0">Select Journal</option>
		<option value="737">AA</option>
		<option value="1408">AAD</option>
		<option value="1406">AAR</option>
		<option value="1002">AASoci</option>
		<option value="2423">AAST</option>
		<option value="164">ABB</option>
		<option value="611">ABC</option>
		<option value="1478">ABCR</option>
		<option value="473">ACES</option>
		<option value="492">ACS</option>
		<option value="1579">ACT</option>
		<option value="2437">AD</option>
		<option value="2442">ADR</option>
		<option value="2444">AE</option>
		<option value="2426">AER</option>
		<option value="2316">AHS</option>
		<option value="803">AID</option>
		<option value="1000">AiM</option>
		<option value="476">AIT</option>
		<option value="203">AJAC</option>
		<option value="2422">AJC</option>
		<option value="1304">AJCC</option>
		<option value="535">AJCM</option>
		<option value="884">AJIBM</option>
		<option value="532">AJMB</option>
		<option value="529">AJOR</option>
		<option value="207">AJPS</option>
		<option value="996">ALAMT</option>
		<option value="1517">ALC</option>
		<option value="2317">ALS</option>
		<option value="160">AM</option>
		<option value="477">AMI</option>
		<option value="675">AMPC</option>
		<option value="1573">ANP</option>
		<option value="1574">APD</option>
		<option value="743">APE</option>
		<option value="513">APM</option>
		<option value="1575">ARS</option>
		<option value="2445">ARSci</option>
		<option value="191">AS</option>
		<option value="812">ASM</option>
		<option value="260">BLR</option>
		<option value="2455">CC</option>
		<option value="136">CE</option>
		<option value="2074">CellBio</option>
		<option value="1493">ChnStd</option>
		<option value="122">CM</option>
		<option value="989">CMB</option>
		<option value="92">CN</option>
		<option value="2033">CRCM</option>
		<option value="173">CS</option>
		<option value="1492">CSTA</option>
		<option value="2438">CUS</option>
		<option value="1518">CWEEE</option>
		<option value="2454">Detection</option>
		<option value="2457">EMAE</option>
		<option value="64">ENG</option>
		<option value="93">EPE</option>
		<option value="1311">ETSN</option>
		<option value="2315">FMAR</option>
		<option value="208">FNS</option>
		<option value="2432">GEP</option>
		<option value="2462">GIS</option>
		<option value="541">GM</option>
		<option value="1690">Graphene</option>
		<option value="512">GSC</option>
		<option value="65">Health</option>
		<option value="103">IB</option>
		<option value="176">ICA</option>
		<option value="111">IIM</option>
		<option value="490">IJAA</option>
		<option value="2449">IJAMSC</option>
		<option value="1391">IJCCE</option>
		<option value="202">IJCM</option>
		<option value="4">IJCNS</option>
		<option value="209">IJG</option>
		<option value="2428">IJIDS</option>
		<option value="747">IJIS</option>
		<option value="1261">IJMNTA</option>
		<option value="1578">IJMPCERO</option>
		<option value="1519">IJNM</option>
		<option value="527">IJOC</option>
		<option value="1477">IJOHNS</option>
		<option value="1298">InfraMatics</option>
		<option value="1980">JACEN</option>
		<option value="2436">JAMP</option>
		<option value="525">JASMI</option>
		<option value="475">JBBS</option>
		<option value="2443">JBCPR</option>
		<option value="30">JBiSE</option>
		<option value="2435">JBM</option>
		<option value="230">JBNB</option>
		<option value="162">JBPC</option>
		<option value="2431">JCC</option>
		<option value="530">JCDSA</option>
		<option value="526">JCPT</option>
		<option value="125">JCT</option>
		<option value="2425">JDAIP</option>
		<option value="479">JDM</option>
		<option value="531">JEAS</option>
		<option value="691">JECTC</option>
		<option value="29">JEMAA</option>
		<option value="144">JEP</option>
		<option value="1986">JFCMV</option>
		<option value="1395">JFRM</option>
		<option value="114">JGIS</option>
		<option value="2461">JHEPGC</option>
		<option value="2421">JHRSS</option>
		<option value="1411">JIBTVA</option>
		<option value="102">JILSA</option>
		<option value="175">JIS</option>
		<option value="648">JMF</option>
		<option value="397">JMGBND</option>
		<option value="1753">JMMCE</option>
		<option value="172">JMP</option>
		<option value="2433">JPEE</option>
		<option value="591">JQIS</option>
		<option value="990">JSBS</option>
		<option value="45">JSEA</option>
		<option value="543">JSEMAT</option>
		<option value="339">JSIP</option>
		<option value="2430">JSS</option>
		<option value="28">JSSM</option>
		<option value="478">JST</option>
		<option value="2439">JTR</option>
		<option value="2460">JTST</option>
		<option value="357">JTTs</option>
		<option value="46">JWARP</option>
		<option value="210">LCE</option>
		<option value="1485">MC</option>
		<option value="163">ME</option>
		<option value="787">MI</option>
		<option value="786">MME</option>
		<option value="917">MNSMS</option>
		<option value="815">MPS</option>
		<option value="2441">MR</option>
		<option value="1487">MRC</option>
		<option value="1576">MRI</option>
		<option value="174">MSA</option>
		<option value="2434">MSCE</option>
		<option value="528">NJGC</option>
		<option value="205">NM</option>
		<option value="192">NR</option>
		<option value="69">NS</option>
		<option value="2459">OALib</option>
		<option value="2463">OALibJ</option>
		<option value="2453">ODEM</option>
		<option value="738">OJA</option>
		<option value="1480">OJAB</option>
		<option value="1590">OJAcct</option>
		<option value="814">OJAnes</option>
		<option value="1407">OJAP</option>
		<option value="1479">OJApo</option>
		<option value="1003">OJAppS</option>
		<option value="2446">OJAPr</option>
		<option value="601">OJAS</option>
		<option value="806">OJBD</option>
		<option value="785">OJBIPHY</option>
		<option value="2447">OJBM</option>
		<option value="2452">OJC</option>
		<option value="997">OJCB</option>
		<option value="606">OJCD</option>
		<option value="788">OJCE</option>
		<option value="792">OJCM</option>
		<option value="1977">OJD</option>
		<option value="810">OJDer</option>
		<option value="586">OJDM</option>
		<option value="614">OJE</option>
		<option value="1577">OJEE</option>
		<option value="2456">OJEM</option>
		<option value="811">OJEMD</option>
		<option value="816">OJEpi</option>
		<option value="1979">OJER</option>
		<option value="736">OJF</option>
		<option value="1004">OJFD</option>
		<option value="587">OJG</option>
		<option value="817">OJGas</option>
		<option value="613">OJGen</option>
		<option value="602">OJI</option>
		<option value="592">OJIC</option>
		<option value="593">OJIM</option>
		<option value="793">OJINM</option>
		<option value="1186">OJL</option>
		<option value="588">OJM</option>
		<option value="790">OJMC</option>
		<option value="784">OJMetal</option>
		<option value="739">OJMH</option>
		<option value="820">OJMI</option>
		<option value="612">OJMIP</option>
		<option value="742">OJML</option>
		<option value="999">OJMM</option>
		<option value="822">OJMN</option>
		<option value="998">OJMP</option>
		<option value="596">OJMS</option>
		<option value="2424">OJMSi</option>
		<option value="605">OJN</option>
		<option value="821">OJNeph</option>
		<option value="804">OJO</option>
		<option value="604">OJOG</option>
		<option value="2464">OJOGas</option>
		<option value="1978">OJOp</option>
		<option value="805">OJOph</option>
		<option value="794">OJOPM</option>
		<option value="823">OJOTS</option>
		<option value="813">OJPathology</option>
		<option value="589">OJPC</option>
		<option value="791">OJPChem</option>
		<option value="609">OJPed</option>
		<option value="610">OJPM</option>
		<option value="741">OJPP</option>
		<option value="744">OJPS</option>
		<option value="603">OJPsych</option>
		<option value="807">OJRA</option>
		<option value="789">OJRad</option>
		<option value="824">OJRD</option>
		<option value="1394">OJRM</option>
		<option value="590">OJS</option>
		<option value="735">OJSS</option>
		<option value="600">OJSST</option>
		<option value="607">OJST</option>
		<option value="1486">OJSTA</option>
		<option value="2448">OJTR</option>
		<option value="808">OJTS</option>
		<option value="509">OJU</option>
		<option value="1001">OJVM</option>
		<option value="547">OPJ</option>
		<option value="71">POS</option>
		<option value="206">PP</option>
		<option value="2440">PST</option>
		<option value="148">PSYCH</option>
		<option value="2450">SAR</option>
		<option value="533">SCD</option>
		<option value="135">SGRE</option>
		<option value="474">SM</option>
		<option value="1589">SN</option>
		<option value="491">SNL</option>
		<option value="2034">Soft</option>
		<option value="204">SS</option>
		<option value="666">TEL</option>
		<option value="104">TI</option>
		<option value="1405">UOAJ</option>
		<option value="2458">VP</option>
		<option value="146">WET</option>
		<option value="511">WJA</option>
		<option value="818">WJCD</option>
		<option value="502">WJCMP</option>
		<option value="809">WJCS</option>
		<option value="2451">WJET</option>
		<option value="506">WJM</option>
		<option value="615">WJNS</option>
		<option value="493">WJNSE</option>
		<option value="534">WJNST</option>
		<option value="510">WJV</option>
		<option value="41">WSN</option>
		<option value="2465">YM</option>

	</select>


                </div>

                <input type="submit" name="ctl00$UserControl_footer$UserControl_NewsletterSubscription$btnSubscribe" value="Subscribe" onclick="return checksubscribe();" id="UserControl_footer_UserControl_NewsletterSubscription_btnSubscribe" class="btn btn-default" style="background: #2f2f2f; border-radius: 5px; color: #fff; padding: 2px 4px;" />


            
</div>


        </div>

    </div>

</div>

        <div class="col-sm-9 column">
        



    <div class="row clearfix foot_links">
        <div class="col-sm-3 col-xs-6 column f_link1" style="margin-bottom: 10px;">
            <ul class="list-unstyled" >
                <li><h4><strong><a href="//www.scirp.org/" target="_top">Home</a></strong></h4></li>
                <li><a href="../journal/indexbytitle" target="_blank">Journals A-Z</a></li>
                <li><a href="../journal/" target="_blank">Subject</a></li>
                <li><a href="../book/" target="_blank">Books</a></li>
                <li><a href="../sitemap/index.xml" target="_blank">Sitemap</a></li>
                <li><a href="../aboutus/#contactus" target="_blank">Contact Us</a></li>
            </ul>
        </div>
        <div class="col-sm-3 col-xs-6 column f_link1" style="margin-bottom: 10px;">
            <ul class="list-unstyled">
                <li><h4><strong><a href="//www.scirp.org/aboutus/" target="_blank">About SCIRP</a></strong></h4></li>
                <li><a href="../aboutus/publicationfees" target="_blank">Publication Fees</a></li>
                <li><a href="../aboutus/forauthors" target="_blank">For Authors</a></li>
                <li><a href="../journal/peer-review" target="_blank">Peer-Review Issues</a></li>
                <li><a href="../journal/callforspecialissueproposals" target="_blank">Special Issues</a></li>
                <li><a href="../news/" target="_blank">News</a></li>
            </ul>
        </div>
        <div class="col-sm-3 col-xs-6 column f_link2" style="margin-bottom: 10px;">
            <ul class="list-unstyled">
                <li><h4><strong><a href="//www.scirp.org/careers/" target="_blank">Service</a></strong></h4></li>
                <li><a href="//papersubmission.scirp.org" target="_blank">Manuscript Tracking System</a></li>
                <li><a href="../aboutus/subscription" target="_blank">Subscription</a></li>
                <li><a href="../author/" target="_blank">Translation & Proofreading</a></li>
                <li><a href="../aboutus/faq" target="_blank">FAQ</a></li>
                <li><a href="//www.scirp.org/journalvolume.html" target="_blank">Volume & Issue</a></li>
            </ul>
        </div>
        <div class="col-sm-3 col-xs-6 column f_link3" style="margin-bottom: 10px;">
            <ul class="list-unstyled">
                <li><h4><strong><a href="//www.scirp.org/aboutus/policies" target="_blank">Policies</a></strong></h4></li>
                <li><a href="../journal/openaccess" target="_blank">Open Access</a></li>
                <li><a href="../aboutus/publicationethics" target="_blank">Publication Ethics</a></li>
                <li><a href="../aboutus/preservation" target="_blank">Preservation</a></li>
                <li><a href="../aboutus/retraction" target="_blank">Retraction</a></li>
                <li><a href="../aboutus/privacypolicy" target="_blank">Privacy Policy</a></li>
            </ul>
        </div>
    </div>


            </div>
    </div>
</div>





<div style="background: #dddddd; line-height: 2em; padding: 10px; color: #666;">
    <div class="text-center">
        Copyright &copy; 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.    
    </div>
</div>

<a href="#0" class="cd-top">Top</a>





        </div>

        <input type="hidden" name="ctl00$Hidden_JournalID" id="Hidden_JournalID" />
    </form>



        <script type="text/javascript">
            $.ajax({
                type: "GET",
                url: "relatedarticles?paperid=" +60000 +"&timspan=" + new Date().getTime(),
            async: true,
            error: function (msg) {
                result = msg;
            },
            success: function (msg) {
                $("#relatedArticles").html(msg);
            }
        });
    </script>

    <script type="text/javascript">
        $.ajax({
            type: "GET",
            url: "journalsponsor?journalid=" +527 +"&timspan=" + new Date().getTime(),
            async: true,
            error: function (msg) {
                result = msg;
            },
            success: function (msg) {
                $("#journalSponsors").html(msg);
            }
        });
    </script>





    <script type="text/javascript">
        $.ajax({
            type: "GET",
            url: "paperviewsdownloads?journalid=" +527 +"&paperid=" +60000 +"&timspan=" + new Date().getTime(),
            async: true,
            error: function (msg) {
                result = msg;
            },
            success: function (msg) {

            }
        });
    </script>






    <!-- jQuery Frameworks    ============================================= -->
    <script src="//www.scirp.org/js/jquery-1.12.4.min.js" type="text/javascript"></script>
    <script src="//www.scirp.org/js/bootstrap.min.js" type="text/javascript"></script>
    <script src="//www.scirp.org/js/main.js" type="text/javascript"></script>
    <script type="text/javascript"  defer="defer" src="//www.scirp.org/js/gtm.js"></script>

   


<script type="text/javascript" src="//www.scirp.org/js/viewer.min.js"></script>
<link rel="stylesheet" href="//www.scirp.org/css/viewer.min.css"  />
<script type="text/javascript">
    $(function () {
        try {
            $("img.lazy").lazyload();
        } catch (e) {

        }

    });
    $(function () {
        try {
            var images = document.querySelectorAll('.lazy');
            images.forEach(function (image) {
                new Viewer(image, {
                    // 在这里定义您的 Viewer 配置选项，和之前示例相同
                    title: false,
                    navbar: false,
                    // ...其他配置
                });
            });
        } catch (e) {

        }

    });
</script>


</body>



</html>
